Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

RGD DISEASE ONTOLOGY - ANNOTATIONS

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.

Term:Drug-Related Side Effects and Adverse Reactions
go back to main search page
Accession:DOID:9006810 term browser browse the term
Definition:Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.
Synonyms:exact_synonym: Adverse Drug Reaction;   Adverse Drug Reactions;   Drug Side Effect;   Drug Side Effects;   Drug Toxicities;   adverse drug event;   adverse drug events;   drug toxicity;   side effects of drugs
 related_synonym: Brain pseudoatrophy, reversible, valproate-induced, susceptibility to
 primary_id: MESH:D064420
For additional species annotation, visit the Alliance of Genome Resources.



show annotations for term's descendants           Sort by:
 
Drug-Related Side Effects and Adverse Reactions term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP-binding cassette, sub-family B (MDR/TAP), member 1A ISO
EXP
CTD Direct Evidence: marker/mechanism CTD PMID:18381794 PMID:20563569 PMID:21064136 PMID:24502637 PMID:25007187 More... NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
JBrowse link
G Abcc1 ATP-binding cassette, sub-family C (CFTR/MRP), member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18256692 NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
JBrowse link
G Abcc12 ATP-binding cassette, sub-family C (CFTR/MRP), member 12 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18466103 NCBI chr 8:87,231,197...87,307,317
Ensembl chr 8:87,208,889...87,307,315
JBrowse link
G Abcc2 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20216337 PMID:23222202 PMID:25007187 PMID:32387182 NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
JBrowse link
G Abcc4 ATP-binding cassette, sub-family C (CFTR/MRP), member 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23222202 NCBI chr14:118,720,104...118,945,475
Ensembl chr14:118,720,104...118,943,631
JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 (Junior blood group) ISO CTD Direct Evidence: marker/mechanism CTD PMID:21064136 PMID:32387182 NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
JBrowse link
G Ache acetylcholinesterase ISO CTD Direct Evidence: therapeutic CTD PMID:27083141 NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
JBrowse link
G Adora1 adenosine A1 receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:15641640 NCBI chr 1:134,126,953...134,163,195
Ensembl chr 1:134,126,961...134,163,169
JBrowse link
G Adora2a adenosine A2a receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:15641640 NCBI chr10:75,152,711...75,170,626
Ensembl chr10:75,152,711...75,170,618
JBrowse link
G Afm afamin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 5:90,666,808...90,701,403
Ensembl chr 5:90,666,791...90,701,402
JBrowse link
G Ahsg alpha-2-HS-glycoprotein ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr16:22,710,765...22,718,201
Ensembl chr16:22,710,027...22,718,199
JBrowse link
G Alb albumin ISO CTD Direct Evidence: marker/mechanism CTD PMID:24361871 PMID:28885000 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
JBrowse link
G Ambp alpha 1 microglobulin/bikunin precursor ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 4:63,061,512...63,072,409
Ensembl chr 4:63,061,512...63,073,036
JBrowse link
G Apob apolipoprotein B ISO CTD Direct Evidence: marker/mechanism CTD PMID:31186542 NCBI chr12:8,027,629...8,066,839
Ensembl chr12:8,027,648...8,066,835
JBrowse link
G Arid5b AT rich interactive domain 5B (MRF1-like) ISO CTD Direct Evidence: marker/mechanism CTD PMID:24712521 NCBI chr10:67,928,353...68,114,596
Ensembl chr10:67,928,350...68,114,570
JBrowse link
G Ass1 argininosuccinate synthetase 1 ISO protein:increased expression:plasma (rat) RGD PMID:20544730 RGD:4140449 NCBI chr 2:31,360,282...31,410,682
Ensembl chr 2:31,360,219...31,410,684
JBrowse link
G Atic 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase ISO CTD Direct Evidence: marker/mechanism CTD PMID:16947783 NCBI chr 1:71,596,315...71,618,562
Ensembl chr 1:71,596,309...71,618,790
JBrowse link
G B2m beta-2 microglobulin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 2:121,978,168...121,983,563
Ensembl chr 2:121,978,167...121,983,564
JBrowse link
G Bche butyrylcholinesterase ISO CTD Direct Evidence: marker/mechanism CTD PMID:3111302 NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748
JBrowse link
G C3 complement component 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
JBrowse link
G Cacna1h calcium channel, voltage-dependent, T type, alpha 1H subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:30552955 NCBI chr17:25,593,259...25,655,308
Ensembl chr17:25,593,259...25,652,757
JBrowse link
G Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 ISO associated with colon cancer RGD PMID:22020760 RGD:15097511 NCBI chr 4:138,182,459...138,187,437
Ensembl chr 4:138,181,625...138,187,434
JBrowse link
G Ccl2 chemokine (C-C motif) ligand 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
JBrowse link
G Ccl4 chemokine (C-C motif) ligand 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509
JBrowse link
G Cda cytidine deaminase ISO DNA:SNP:cds:rs1048977|rs12726436|rs2072671 (human) RGD PMID:28347776 RGD:152995291 NCBI chr 4:138,065,839...138,095,623
Ensembl chr 4:138,065,735...138,095,303
JBrowse link
G Ces1c carboxylesterase 1C EXP CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 8:93,825,643...93,857,911
Ensembl chr 8:93,825,643...93,857,911
JBrowse link
G Ces2h carboxylesterase 2H ISO CTD Direct Evidence: marker/mechanism CTD PMID:19931604 NCBI chr 8:105,727,462...105,747,042
Ensembl chr 8:105,727,485...105,747,810
JBrowse link
G Clu clusterin ISO CTD Direct Evidence: marker/mechanism CTD PMID:24361871 PMID:28885000 NCBI chr14:66,205,932...66,218,997
Ensembl chr14:66,205,932...66,218,996
JBrowse link
G Commd1 COMM domain containing 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23583003 NCBI chr11:22,849,728...22,934,539
Ensembl chr11:22,846,136...22,932,382
JBrowse link
G Cp ceruloplasmin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 3:20,011,097...20,063,914
Ensembl chr 3:20,011,218...20,063,309
JBrowse link
G Csf2 colony stimulating factor 2 (granulocyte-macrophage) ISO CTD Direct Evidence: therapeutic CTD PMID:7960606 NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
JBrowse link
G Csf3 colony stimulating factor 3 (granulocyte) ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:7692001 PMID:27737899 PMID:31557154 NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
JBrowse link
G Cst3 cystatin C ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 2:148,713,642...148,717,432
Ensembl chr 2:148,713,642...148,717,612
JBrowse link
G Cxcl15 chemokine (C-X-C motif) ligand 15 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:10445756 NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
JBrowse link
G Cyp2c29 cytochrome P450, family 2, subfamily c, polypeptide 29 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27736846 NCBI chr19:39,275,488...39,319,157
Ensembl chr19:39,257,849...39,319,157
JBrowse link
G Cyp2c65 cytochrome P450, family 2, subfamily c, polypeptide 65 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11740344 PMID:19925388 PMID:23104259 NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
JBrowse link
G Cyp2c66 cytochrome P450, family 2, subfamily c, polypeptide 66 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11740344 PMID:19925388 PMID:23104259 NCBI chr19:39,102,342...39,175,200
Ensembl chr19:39,102,342...39,175,516
JBrowse link
G Cyp2d22 cytochrome P450, family 2, subfamily d, polypeptide 22 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23609392 NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18990727 NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
JBrowse link
G Dhfr dihydrofolate reductase ISO CTD Direct Evidence: marker/mechanism CTD PMID:21064136 NCBI chr13:92,491,291...92,525,561
Ensembl chr13:92,491,234...92,525,561
JBrowse link
G Dip2b disco interacting protein 2 homolog B ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr15:99,935,119...100,117,355
Ensembl chr15:99,936,545...100,117,354
JBrowse link
G Dpyd dihydropyrimidine dehydrogenase ISO DNA:SNP:cds:rs12119882 (human) RGD PMID:28347776 RGD:152995291 NCBI chr 3:118,355,758...119,226,573
Ensembl chr 3:118,355,778...119,226,573
JBrowse link
G Epha7 Eph receptor A7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30357299 NCBI chr 4:28,811,840...28,969,391
Ensembl chr 4:28,813,131...28,967,499
JBrowse link
G Ephx2 epoxide hydrolase 2, cytoplasmic ISO CTD Direct Evidence: therapeutic CTD PMID:26165641 NCBI chr14:66,321,821...66,361,971
Ensembl chr14:66,321,823...66,361,949
JBrowse link
G Ercc1 excision repair cross-complementing rodent repair deficiency, complementation group 1 treatment ISO associated with Breast Neoplasms;DNA:SNP: :p.Q504K (human)
associated with Leukemia, Myeloid, Acute
RGD PMID:25495407 PMID:17197435 RGD:11252168, RGD:11252178 NCBI chr 7:19,075,769...19,090,449
Ensembl chr 7:19,078,703...19,090,449
JBrowse link
G Ercc2 excision repair cross-complementing rodent repair deficiency, complementation group 2 treatment ISO DNA:SNP: :p.K751Q (rs13181) (human)
associated with Leukemia, Myeloid, Acute;DNA:SNPs, haplotypes: :p.D312N, p.K751Q (human)
RGD PMID:15339847 PMID:17197435 RGD:11252202, RGD:11252178 NCBI chr 7:19,115,942...19,129,619
Ensembl chr 7:19,115,935...19,129,619
JBrowse link
G Fga fibrinogen alpha chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:15805072 NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934
JBrowse link
G Fndc3b fibronectin type III domain containing 3B ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 3:27,470,284...27,765,469
Ensembl chr 3:27,470,311...27,765,456
JBrowse link
G Gata4 GATA binding protein 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31190750 NCBI chr14:63,436,363...63,509,161
Ensembl chr14:63,436,371...63,509,141
JBrowse link
G Gata6 GATA binding protein 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31190750 NCBI chr18:11,052,510...11,085,636
Ensembl chr18:11,052,064...11,085,635
JBrowse link
G Gc vitamin D binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757
JBrowse link
G H2-M2 histocompatibility 2, M region locus 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:3084782 PMID:3133153 PMID:3157529 PMID:3437418 PMID:6770269 More... NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443
JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15805072 PMID:24361871 PMID:28885000 NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
JBrowse link
G Hmgb1 high mobility group box 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27474498 NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
JBrowse link
G Hmox1 heme oxygenase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18227147 NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
JBrowse link
G Homer1 homer scaffolding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24126708 NCBI chr13:93,440,265...93,549,471
Ensembl chr13:93,436,143...93,541,637
JBrowse link
G Hp haptoglobin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
JBrowse link
G Hpx hemopexin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 7:105,240,818...105,249,323
Ensembl chr 7:105,240,820...105,249,344
JBrowse link
G Hspb6 heat shock protein, alpha-crystallin-related, B6 ISO CTD Direct Evidence: therapeutic CTD PMID:18948619 NCBI chr 7:30,251,961...30,254,868
Ensembl chr 7:30,251,603...30,254,868
JBrowse link
G Htr2b 5-hydroxytryptamine (serotonin) receptor 2B ISO CTD Direct Evidence: marker/mechanism CTD PMID:16863450 NCBI chr 1:86,025,268...86,043,960
Ensembl chr 1:86,026,748...86,039,692
JBrowse link
G Ifng interferon gamma ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
JBrowse link
G Igf1 insulin-like growth factor 1 ISO CTD Direct Evidence: therapeutic CTD PMID:20064577 NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15805072 NCBI chr11:7,147,787...7,152,546
Ensembl chr11:7,147,782...7,152,546
JBrowse link
G Il10 interleukin 10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
JBrowse link
G Il1rn interleukin 1 receptor antagonist ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
JBrowse link
G Il3 interleukin 3 ISO CTD Direct Evidence: therapeutic CTD PMID:8202718 NCBI chr11:54,155,911...54,158,105
Ensembl chr11:54,156,129...54,158,103
JBrowse link
G Il6 interleukin 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
JBrowse link
G Kitl kit ligand ISO CTD Direct Evidence: therapeutic CTD PMID:1720698 NCBI chr10:99,851,477...99,936,278
Ensembl chr10:99,851,492...99,936,278
JBrowse link
G Lcn2 lipocalin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
JBrowse link
G Ltbr lymphotoxin B receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 6:125,283,534...125,291,026
Ensembl chr 6:125,283,534...125,290,848
JBrowse link
G Mapk14 mitogen-activated protein kinase 14 susceptibility ISO associated with lung non-small cell carcinoma;DNA:SNP:3' utr, intron: (rs3804451) (human) RGD PMID:26993769 RGD:151665351 NCBI chr17:28,910,243...28,967,379
Ensembl chr17:28,910,303...28,967,380
JBrowse link
G Mocos molybdenum cofactor sulfurase ISO CTD Direct Evidence: marker/mechanism CTD PMID:29935280 NCBI chr18:24,786,538...24,834,634
Ensembl chr18:24,786,748...24,834,632
JBrowse link
G mt-Atp8 ATP synthase 8, mitochondrial ISO ClinVar Annotator: match by term: Brain pseudoatrophy, reversible, valproate-induced, susceptibility to ClinVar PMID:9243242 PMID:17101920 NCBI chr MT:7,766...7,969
Ensembl chr MT:7,766...7,969
JBrowse link
G Mthfr methylenetetrahydrofolate reductase ISO CTD Direct Evidence: marker/mechanism CTD PMID:15753437 PMID:16166815 PMID:17387702 PMID:17502830 PMID:18551038 More... NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
JBrowse link
G Mtr 5-methyltetrahydrofolate-homocysteine methyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:15753437 PMID:19159907 NCBI chr13:12,196,217...12,273,090
Ensembl chr13:12,197,598...12,272,999
JBrowse link
G Mtrr 5-methyltetrahydrofolate-homocysteine methyltransferase reductase ISO CTD Direct Evidence: marker/mechanism CTD PMID:21064136 NCBI chr13:68,708,899...68,730,288
Ensembl chr13:68,708,899...68,730,268
JBrowse link
G Mug1 murinoglobulin 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 6:121,815,455...121,866,016
Ensembl chr 6:121,815,500...121,866,016
JBrowse link
G Nat1 N-acetyl transferase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11505221 NCBI chr 8:67,943,620...67,945,183
Ensembl chr 8:67,933,573...67,944,756
JBrowse link
G Nat2 N-acetyltransferase 2 (arylamine N-acetyltransferase) susceptibility ISO DNA:polymorphism: :
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:17377643 PMID:17502830 PMID:12786839 RGD:8552667 NCBI chr 8:67,947,527...67,955,296
Ensembl chr 8:67,947,510...67,955,236
JBrowse link
G Nfe2l2 nuclear factor, erythroid derived 2, like 2 ISO CTD Direct Evidence: therapeutic CTD PMID:20605904 NCBI chr 2:75,505,857...75,535,007
Ensembl chr 2:75,505,857...75,534,985
JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29802709 NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
JBrowse link
G Nt5c2 5'-nucleotidase, cytosolic II ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr19:46,873,829...47,003,613
Ensembl chr19:46,871,756...47,003,592
JBrowse link
G Orm1 orosomucoid 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 4:63,262,793...63,266,400
Ensembl chr 4:63,262,797...63,266,400
JBrowse link
G Peli1 pellino 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr11:21,041,283...21,100,327
Ensembl chr11:21,041,291...21,100,323
JBrowse link
G Plg plasminogen ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr17:12,597,496...12,638,271
Ensembl chr17:12,597,495...12,638,272
JBrowse link
G Plk2 polo like kinase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12897130 NCBI chr13:110,531,578...110,537,378
Ensembl chr13:110,531,580...110,537,378
JBrowse link
G Ppara peroxisome proliferator activated receptor alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:19683050 NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:10698006 NCBI chr 1:149,975,782...149,983,985
Ensembl chr 1:149,975,782...149,983,978
JBrowse link
G Ren1 renin 1 structural ISO CTD Direct Evidence: marker/mechanism CTD PMID:8723173 NCBI chr 1:133,278,412...133,288,058
Ensembl chr 1:133,278,248...133,288,063
JBrowse link
G Shmt1 serine hydroxymethyltransferase 1 (soluble) ISO CTD Direct Evidence: marker/mechanism CTD PMID:21064136 NCBI chr11:60,678,933...60,702,091
Ensembl chr11:60,678,930...60,702,544
JBrowse link
G Slc19a1 solute carrier family 19 (folate transporter), member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21064136 NCBI chr10:76,868,103...76,886,266
Ensembl chr10:76,868,075...76,896,836
JBrowse link
G Slc22a7 solute carrier family 22 (organic anion transporter), member 7 ISO DNA:SNP:cds:rs2270860|rs4149178 (human) RGD PMID:28347776 RGD:152995291 NCBI chr17:46,743,111...46,749,403
Ensembl chr17:46,743,109...46,749,383
JBrowse link
G Slc34a2 solute carrier family 34 (sodium phosphate), member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15805072 NCBI chr 5:53,206,695...53,229,006
Ensembl chr 5:53,195,423...53,229,006
JBrowse link
G Slco2a1 solute carrier organic anion transporter family, member 2a1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15805072 NCBI chr 9:102,885,686...102,973,201
Ensembl chr 9:102,865,911...102,973,201
JBrowse link
G Sod1 superoxide dismutase 1, soluble ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
JBrowse link
G Spp1 secreted phosphoprotein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15805072 NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
JBrowse link
G Tcn2 transcobalamin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15753437 NCBI chr11:3,867,077...3,882,078
Ensembl chr11:3,867,192...3,882,159
JBrowse link
G Thbd thrombomodulin ISO CTD Direct Evidence: therapeutic CTD PMID:27474498 NCBI chr 2:148,246,391...148,250,108
Ensembl chr 2:148,246,386...148,250,108
JBrowse link
G Tlr1 toll-like receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18466103 NCBI chr 5:65,082,023...65,090,945
Ensembl chr 5:65,082,022...65,090,906
JBrowse link
G Tlr2 toll-like receptor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18466103 PMID:31557154 NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
JBrowse link
G Tnf tumor necrosis factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Top1 topoisomerase (DNA) I ISO CTD Direct Evidence: marker/mechanism CTD PMID:19931604 NCBI chr 2:160,487,817...160,564,684
Ensembl chr 2:160,487,808...160,564,684
JBrowse link
G Trf transferrin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 9:103,086,075...103,107,485
Ensembl chr 9:103,081,200...103,107,643
JBrowse link
G Trp53 transformation related protein 53 EXP CTD Direct Evidence: marker/mechanism CTD PMID:9369336 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
JBrowse link
G Ttr transthyretin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr18:20,797,266...20,807,383
Ensembl chr18:20,798,337...20,807,378
JBrowse link
G Txn1 thioredoxin 1 EXP CTD Direct Evidence: therapeutic CTD PMID:11462148 NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411
JBrowse link
G Tyms thymidylate synthase ISO CTD Direct Evidence: marker/mechanism
DNA:SNP:cds:rs2853741 (human)
CTD
RGD
PMID:19648163 PMID:21064136 PMID:25007187 PMID:26077125 PMID:28347776 RGD:152995291 NCBI chr 5:30,243,544...30,279,261
Ensembl chr 5:30,263,200...30,278,615
JBrowse link
G Ugt1a1 UDP glucuronosyltransferase 1 family, polypeptide A1 ISO CTD Direct Evidence: therapeutic CTD PMID:19931604 NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
JBrowse link
G Umps uridine monophosphate synthetase ISO DNA:SNP:cds:rs2279199|rs4678145 (human) RGD PMID:28347776 RGD:152995291 NCBI chr16:33,775,152...33,787,408
Ensembl chr16:33,775,152...33,787,408
JBrowse link
G Vegfa vascular endothelial growth factor A ISO CTD Direct Evidence: marker/mechanism CTD PMID:31068094 NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
JBrowse link
G Vkorc1 vitamin K epoxide reductase complex, subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26445138 NCBI chr 7:127,492,235...127,494,833
Ensembl chr 7:127,485,399...127,494,626
Ensembl chr 7:127,485,399...127,494,626
JBrowse link
abacavir allergy term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G H2-M2 histocompatibility 2, M region locus 2 ISO ClinVar Annotator: match by term: Abacavir hypersensitivity ClinVar
OMIM
PMID:11888582 PMID:11943262 PMID:12462283 PMID:15024131 PMID:15247624 More... NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443
JBrowse link
Anthracycline-induced Cardiotoxicity term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP-binding cassette, sub-family B (MDR/TAP), member 1A susceptibility ISO DNA:missense mutation:cds:p.G671V (human) RGD PMID:16330681 RGD:11041175 NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
JBrowse link
G Capn2 calpain 2 treatment ISO RGD PMID:25634181 RGD:13792617 NCBI chr 1:182,294,818...182,345,175
Ensembl chr 1:182,294,825...182,345,173
JBrowse link
G Ercc2 excision repair cross-complementing rodent repair deficiency, complementation group 2 ISO associated with Leukemia, Myeloid, Acute;DNA:SNP:exon:p.K751Q (rs13181) (human) RGD PMID:24284041 RGD:11252190 NCBI chr 7:19,115,942...19,129,619
Ensembl chr 7:19,115,935...19,129,619
JBrowse link
aspirin-induced respiratory disease term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cacng6 calcium channel, voltage-dependent, gamma subunit 6 susceptibility ISO DNA:SNP,haplotype:rs192808(human) RGD PMID:20860846 RGD:13524562 NCBI chr 7:3,472,017...3,484,183
Ensembl chr 7:3,472,711...3,484,183
JBrowse link
G Ccr3 chemokine (C-C motif) receptor 3 ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:20485159 PMID:20022477 RGD:4145619 NCBI chr 9:123,817,799...123,831,729
Ensembl chr 9:123,822,009...123,831,726
JBrowse link
G Cysltr1 cysteinyl leukotriene receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16502481 PMID:17641958 PMID:20485159 NCBI chr  X:105,617,952...105,647,329
Ensembl chr  X:105,617,952...105,647,285
JBrowse link
G Cysltr2 cysteinyl leukotriene receptor 2 ISO DNA:SNPs: :-819T>G, 2078C>T, 2534A>G (human)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:16502481 PMID:20485159 PMID:15970796 RGD:5144000 NCBI chr14:73,263,515...73,286,554
Ensembl chr14:73,263,043...73,286,554
JBrowse link
G Fancc Fanconi anemia, complementation group C ISO DNA:haplotype::rs4647416(human) RGD PMID:21670957 RGD:11045795 NCBI chr13:63,452,519...63,645,126
Ensembl chr13:63,432,857...63,645,092
JBrowse link
G H2-Aa histocompatibility 2, class II antigen A, alpha susceptibility ISO RGD PMID:25975240 RGD:11074090 NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797
JBrowse link
G H2-Ab1 histocompatibility 2, class II antigen A, beta 1 susceptibility ISO RGD PMID:25975240 RGD:11074090 NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
JBrowse link
G H2-Eb1 histocompatibility 2, class II antigen E beta susceptibility ISO RGD PMID:25975240 RGD:11074090 NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648
JBrowse link
G Il4 interleukin 4 susceptibility ISO DNA:SNPs:promoter,5'UTR,intron:multiple RGD PMID:20921925 RGD:11528633 NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
JBrowse link
G Ltc4s leukotriene C4 synthase ISO CTD Direct Evidence: marker/mechanism CTD PMID:9393345 PMID:9466979 PMID:10970818 PMID:20485159 NCBI chr11:50,127,288...50,129,378
Ensembl chr11:50,127,288...50,129,443
JBrowse link
G Ms4a2 membrane-spanning 4-domains, subfamily A, member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16502481 NCBI chr19:11,592,881...11,601,154
Ensembl chr19:11,592,887...11,601,083
JBrowse link
G Postn periostin, osteoblast specific factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:18391768 NCBI chr 3:54,266,688...54,298,462
Ensembl chr 3:54,268,530...54,298,458
JBrowse link
G Ptgdr2 prostaglandin D2 receptor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr19:10,901,883...10,919,875
Ensembl chr19:10,914,524...10,919,875
JBrowse link
G Ptger2 prostaglandin E receptor 2 (subtype EP2) ISO ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to
CTD Direct Evidence: marker/mechanism
ClinVar
CTD
PMID:15496426 PMID:16502481 NCBI chr14:45,225,568...45,241,277
Ensembl chr14:45,225,652...45,241,277
JBrowse link
G Ptgir prostaglandin I receptor (IP) ISO CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr 7:16,640,415...16,644,830
Ensembl chr 7:16,640,415...16,644,830
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 ISO protein:increased expression:mast cell
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:16502481 PMID:20485159 PMID:9487340 RGD:5143936 NCBI chr 1:149,975,782...149,983,985
Ensembl chr 1:149,975,782...149,983,978
JBrowse link
G Tap2 transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) ISO RGD PMID:21796142 RGD:5147839 NCBI chr17:34,423,453...34,435,295
Ensembl chr17:34,422,501...34,435,295
JBrowse link
G Tbx21 T-box 21 ISO ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to
CTD Direct Evidence: marker/mechanism
ClinVar
CTD
PMID:15806396 PMID:16502481 NCBI chr11:96,988,833...97,006,157
Ensembl chr11:96,988,897...97,006,157
JBrowse link
G Tbxa2r thromboxane A2 receptor susceptibility ISO DNA:polymorphism: :795T>C (human)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:16502481 PMID:20485159 PMID:15898979 RGD:11059537 NCBI chr10:81,164,102...81,171,008
Ensembl chr10:81,164,565...81,171,006
JBrowse link
asthma, nasal polyps, and aspirin intolerance term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Alox15 arachidonate 15-lipoxygenase ISO ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance ClinVar PMID:17959182 PMID:21558275 PMID:30643255 NCBI chr11:70,234,973...70,279,465
Ensembl chr11:70,234,978...70,242,857
JBrowse link
G Ptger2 prostaglandin E receptor 2 (subtype EP2) ISO OMIM NCBI chr14:45,225,568...45,241,277
Ensembl chr14:45,225,652...45,241,277
JBrowse link
G Tbx21 T-box 21 ISO ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance OMIM
ClinVar
PMID:25741868 NCBI chr11:96,988,833...97,006,157
Ensembl chr11:96,988,897...97,006,157
JBrowse link
Cardiotoxicity term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Agt angiotensinogen (serpin peptidase inhibitor, clade A, member 8) ISO CTD Direct Evidence: marker/mechanism CTD PMID:33676887 NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
JBrowse link
G Bche butyrylcholinesterase ISO CTD Direct Evidence: therapeutic CTD PMID:26145887 NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748
JBrowse link
G Bmp2 bone morphogenetic protein 2 ISO CTD Direct Evidence: therapeutic CTD PMID:29800642 NCBI chr 2:133,394,079...133,404,816
Ensembl chr 2:133,394,079...133,404,805
JBrowse link
G Ccl2 chemokine (C-C motif) ligand 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29959987 NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
JBrowse link
G Csf1 colony stimulating factor 1 (macrophage) ISO CTD Direct Evidence: marker/mechanism CTD PMID:32068018 NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785
JBrowse link
G Cxcl15 chemokine (C-X-C motif) ligand 15 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29959987 NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
JBrowse link
G Fas Fas (TNF receptor superfamily member 6) ISO CTD Direct Evidence: marker/mechanism CTD PMID:34713381 NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
JBrowse link
G Fasl Fas ligand (TNF superfamily, member 6) ISO
EXP
CTD Direct Evidence: marker/mechanism CTD PMID:34713381 NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
JBrowse link
G Hbegf heparin-binding EGF-like growth factor ISO CTD Direct Evidence: therapeutic CTD PMID:29305325 NCBI chr18:36,637,980...36,648,858
Ensembl chr18:36,637,980...36,648,858
JBrowse link
G Il1b interleukin 1 beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:32068018 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
JBrowse link
G Mettl14 methyltransferase like 14 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34648132 NCBI chr 3:123,161,944...123,179,639
Ensembl chr 3:123,161,946...123,179,757
JBrowse link
G Mir208a microRNA 208a ISO CTD Direct Evidence: marker/mechanism CTD PMID:26454886 NCBI chr14:55,186,517...55,186,599
Ensembl chr14:55,186,517...55,186,599
JBrowse link
G Nos3 nitric oxide synthase 3, endothelial cell treatment ISO associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:polymorphism: :894G>T(human) RGD PMID:26345518 RGD:11533645 NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
JBrowse link
G Nppb natriuretic peptide type B ISO CTD Direct Evidence: marker/mechanism CTD PMID:29959987 NCBI chr 4:148,070,264...148,071,662
Ensembl chr 4:148,070,245...148,071,662
JBrowse link
G Nrg1 neuregulin 1 ISO CTD Direct Evidence: therapeutic CTD PMID:29305325 NCBI chr 8:32,299,493...33,381,858
Ensembl chr 8:32,304,579...33,374,825
Ensembl chr 8:32,304,579...33,374,825
JBrowse link
G Rac1 Rac family small GTPase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28710503 NCBI chr 5:143,491,236...143,513,786
Ensembl chr 5:143,489,389...143,513,791
JBrowse link
G Rarg retinoic acid receptor, gamma ISO CTD Direct Evidence: marker/mechanism CTD PMID:26237429 NCBI chr15:102,143,373...102,165,957
Ensembl chr15:102,143,373...102,165,952
JBrowse link
G Sirt6 sirtuin 6 ISO CTD Direct Evidence: therapeutic CTD PMID:34713381 NCBI chr10:81,457,621...81,463,631
Ensembl chr10:81,457,619...81,463,631
JBrowse link
G Tlr2 toll-like receptor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29959987 NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
JBrowse link
G Tnf tumor necrosis factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:29959987 PMID:32068018 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Trp53 transformation related protein 53 EXP
ISO
CTD Direct Evidence: marker/mechanism CTD PMID:30009776 PMID:34713381 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
JBrowse link
Chemical and Drug Induced Liver Injury term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aass aminoadipate-semialdehyde synthase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:23,072,172...23,132,985
Ensembl chr 6:23,072,172...23,132,985
JBrowse link
G Abcb11 ATP-binding cassette, sub-family B (MDR/TAP), member 11 severity ISO DNA:SNP: :rs2287616(human) RGD PMID:27293027 RGD:14402413 NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,960
JBrowse link
G Abcb1a ATP-binding cassette, sub-family B (MDR/TAP), member 1A severity
susceptibility
IMP
ISO
EXP
DNA:SNP::2677G>T/A(rs2032582)(human)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:20623750 PMID:26134275 PMID:26134275 PMID:27296832 RGD:11041130, RGD:14700895 NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
JBrowse link
G Abcb1b ATP-binding cassette, sub-family B (MDR/TAP), member 1B EXP CTD Direct Evidence: marker/mechanism CTD PMID:27193730 NCBI chr 5:8,848,147...8,916,314
Ensembl chr 5:8,848,147...8,916,315
JBrowse link
G Abcc1 ATP-binding cassette, sub-family C (CFTR/MRP), member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18466103 NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
JBrowse link
G Abcc2 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 susceptibility ISO CTD Direct Evidence: marker/mechanism
DNA:polymorphism:promoter:-24C>T(human)
CTD
RGD
PMID:18381794 PMID:18466103 PMID:17241877 PMID:25196354 RGD:14700814, RGD:14700812 NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
JBrowse link
G Abi1 abl interactor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 2:22,830,085...22,930,275
Ensembl chr 2:22,830,085...22,930,253
JBrowse link
G Ace angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 ISO mRNA:increased expression:liver (rat) RGD PMID:25143335 RGD:25671447 NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
JBrowse link
G Acox3 acyl-Coenzyme A oxidase 3, pristanoyl ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 5:35,740,293...35,772,397
Ensembl chr 5:35,740,384...35,772,696
JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 8:46,924,074...46,989,088
Ensembl chr 8:46,924,074...46,989,088
JBrowse link
G Actb actin, beta ISO mRNA:increased expression:liver
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:25231249 PMID:22563491 RGD:9587759 NCBI chr 5:142,888,870...142,892,509
Ensembl chr 5:142,888,870...142,892,509
JBrowse link
G Actn4 actinin alpha 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 7:28,592,673...28,661,799
Ensembl chr 7:28,592,673...28,661,765
JBrowse link
G Actr3 ARP3 actin-related protein 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:125,320,642...125,363,464
Ensembl chr 1:125,320,642...125,363,464
JBrowse link
G Ada adenosine deaminase ISO protein:increased expression:liver RGD PMID:21161045 RGD:5128859 NCBI chr 2:163,568,491...163,592,161
Ensembl chr 2:163,568,504...163,592,159
JBrowse link
G Adam8 a disintegrin and metallopeptidase domain 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24646716 NCBI chr 7:139,558,845...139,573,016
Ensembl chr 7:139,558,845...139,572,475
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing ISO CTD Direct Evidence: therapeutic CTD PMID:20709802 NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
JBrowse link
G Adipor2 adiponectin receptor 2 severity ISO associated with obesity, LPS;mRNA:decreased expression:liver (rat) RGD PMID:23838384 RGD:8695926 NCBI chr 6:119,330,111...119,394,489
Ensembl chr 6:119,330,111...119,394,665
JBrowse link
G Agt angiotensinogen (serpin peptidase inhibitor, clade A, member 8) ISO CTD Direct Evidence: marker/mechanism CTD PMID:29499335 NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
JBrowse link
G Ahr aryl-hydrocarbon receptor ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:21890736 PMID:34848246 NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
JBrowse link
G Aifm1 apoptosis-inducing factor, mitochondrion-associated 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25743375 NCBI chr  X:47,563,821...47,602,440
Ensembl chr  X:47,563,821...47,602,440
JBrowse link
G Ak4 adenylate kinase 4 ISO protein:increased expression:liver (rat) RGD PMID:16538043 RGD:2301096 NCBI chr 4:101,273,675...101,324,968
Ensembl chr 4:101,276,474...101,324,192
JBrowse link
G Akr1a1 aldo-keto reductase family 1, member A1 (aldehyde reductase) IMP
ISO
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:32805337 PMID:29763686 RGD:27226688 NCBI chr 4:116,493,707...116,508,871
Ensembl chr 4:116,493,707...116,508,877
JBrowse link
G Alb albumin treatment ISO
IEP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:18779383 PMID:22310181 PMID:27567545 RGD:14694844 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
JBrowse link
G Aldh1l2 aldehyde dehydrogenase 1 family, member L2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr10:83,320,386...83,370,008
Ensembl chr10:83,323,314...83,370,004
JBrowse link
G Aldh2 aldehyde dehydrogenase 2, mitochondrial severity
susceptibility
ISO
IMP
protein:increased expression:liver
DNA:deletion:exon 3 (mouse)
RGD PMID:21138988 PMID:30121625 PMID:24492981 RGD:7241599, RGD:15036810, RGD:14975148 NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
JBrowse link
G Aldh9a1 aldehyde dehydrogenase 9, subfamily A1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:167,177,532...167,196,099
Ensembl chr 1:167,177,560...167,196,101
JBrowse link
G Aldob aldolase B, fructose-bisphosphate ISO CTD Direct Evidence: marker/mechanism CTD PMID:16115720 NCBI chr 4:49,535,993...49,549,546
Ensembl chr 4:49,535,995...49,549,546
JBrowse link
G Ambp alpha 1 microglobulin/bikunin precursor ISO CTD Direct Evidence: marker/mechanism CTD PMID:18779383 NCBI chr 4:63,061,512...63,072,409
Ensembl chr 4:63,061,512...63,073,036
JBrowse link
G Anxa2 annexin A2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 9:69,360,965...69,399,074
Ensembl chr 9:69,360,902...69,399,077
JBrowse link
G Anxa6 annexin A6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:54,869,779...54,924,297
Ensembl chr11:54,869,934...54,924,271
JBrowse link
G Apoa1 apolipoprotein A-I ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
JBrowse link
G Apoe apolipoprotein E ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
JBrowse link
G Apoh apolipoprotein H ISO mRNA:increased expression:plasma:
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:16099942 PMID:23288050 RGD:10054107 NCBI chr11:108,286,123...108,305,222
Ensembl chr11:108,234,180...108,305,222
JBrowse link
G Arg1 arginase, liver ISO CTD Direct Evidence: marker/mechanism CTD PMID:22872058 NCBI chr10:24,791,105...24,803,368
Ensembl chr10:24,791,119...24,803,382
JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator ISO CTD Direct Evidence: marker/mechanism CTD PMID:20935161 NCBI chr 3:95,341,674...95,404,551
Ensembl chr 3:95,341,699...95,404,551
JBrowse link
G Atg5 autophagy related 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22491424 NCBI chr10:44,144,325...44,240,295
Ensembl chr10:44,144,354...44,240,287
JBrowse link
G Atoh8 atonal bHLH transcription factor 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 6:72,183,158...72,212,765
Ensembl chr 6:72,183,161...72,212,561
JBrowse link
G Atp6v1d ATPase, H+ transporting, lysosomal V1 subunit D ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr12:78,889,756...78,908,810
Ensembl chr12:78,887,499...78,908,412
JBrowse link
G Bad BCL2-associated agonist of cell death treatment ISO RGD PMID:25447754 RGD:10053709 NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
JBrowse link
G Bax BCL2-associated X protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:17906064 NCBI chr 7:45,111,119...45,116,344
Ensembl chr 7:45,111,121...45,116,322
JBrowse link
G Bdh1 3-hydroxybutyrate dehydrogenase, type 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr16:31,241,115...31,277,719
Ensembl chr16:31,241,098...31,277,719
JBrowse link
G Bdkrb2 bradykinin receptor, beta 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30685357 NCBI chr12:105,529,431...105,561,503
Ensembl chr12:105,529,485...105,561,496
JBrowse link
G Blvrb biliverdin reductase B (flavin reductase (NADPH)) ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 7:27,147,403...27,165,406
Ensembl chr 7:27,147,403...27,165,569
JBrowse link
G Bpnt1 3'(2'), 5'-bisphosphate nucleotidase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:185,061,619...185,089,974
Ensembl chr 1:185,064,346...185,089,974
JBrowse link
G Brd4 bromodomain containing 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr17:32,415,246...32,503,717
Ensembl chr17:32,415,248...32,503,696
JBrowse link
G Btd biotinidase ISO CTD Direct Evidence: marker/mechanism CTD PMID:15469856 NCBI chr14:31,363,014...31,390,154
Ensembl chr14:31,362,985...31,390,536
JBrowse link
G C3 complement component 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
JBrowse link
G Cabp1 calcium binding protein 1 ISO protein:increased expression:liver RGD PMID:21138988 RGD:7241599 NCBI chr 5:115,306,750...115,332,440
Ensembl chr 5:115,306,748...115,332,440
JBrowse link
G Cadps2 Ca2+-dependent activator protein for secretion 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 6:23,262,772...23,840,662
Ensembl chr 6:23,262,772...23,839,420
JBrowse link
G Canx calnexin ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:50,184,784...50,216,500
Ensembl chr11:50,184,788...50,216,500
JBrowse link
G Cap1 CAP, adenylate cyclase-associated protein 1 (yeast) ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:122,752,841...122,779,869
Ensembl chr 4:122,752,840...122,779,849
JBrowse link
G Car3 carbonic anhydrase 3 EXP
ISO
CTD Direct Evidence: marker/mechanism CTD PMID:25226513 PMID:25231249 NCBI chr 3:14,928,598...14,937,441
Ensembl chr 3:14,928,572...14,937,583
JBrowse link
G Casp8 caspase 8 treatment ISO RGD PMID:25447754 RGD:10053709 NCBI chr 1:58,834,398...58,886,662
Ensembl chr 1:58,834,533...58,886,662
JBrowse link
G Cast calpastatin ISO RGD PMID:16871587 RGD:5683869 NCBI chr13:74,840,485...74,956,993
Ensembl chr13:74,840,487...74,956,929
JBrowse link
G Cat catalase ISO CTD Direct Evidence: marker/mechanism
protein:decreased expression:liver
CTD
RGD
PMID:20623750 PMID:25231249 PMID:21138988 RGD:7241599 NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
JBrowse link
G Ccdc80 coiled-coil domain containing 80 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr16:44,913,770...44,948,287
Ensembl chr16:44,913,765...44,948,440
JBrowse link
G Ccl2 chemokine (C-C motif) ligand 2 treatment ISO
IMP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:20623750 PMID:21813474 PMID:30663942 RGD:14995466, RGD:14995458 NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
JBrowse link
G Ccr2 chemokine (C-C motif) receptor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
JBrowse link
G Ccr5 chemokine (C-C motif) receptor 5 susceptibility IMP acetaminophen RGD PMID:24770590 RGD:14401733 NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
JBrowse link
G Cct3 chaperonin containing Tcp1, subunit 3 (gamma) ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 3:88,204,442...88,229,073
Ensembl chr 3:88,204,423...88,229,074
JBrowse link
G Cct5 chaperonin containing Tcp1, subunit 5 (epsilon) ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr15:31,590,946...31,601,992
Ensembl chr15:31,590,946...31,601,950
JBrowse link
G Cdc25b cell division cycle 25B ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 2:131,028,356...131,040,431
Ensembl chr 2:131,028,869...131,040,417
JBrowse link
G Cds1 CDP-diacylglycerol synthase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 5:101,912,996...101,971,724
Ensembl chr 5:101,912,996...101,971,724
JBrowse link
G Cela1 chymotrypsin-like elastase family, member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr15:100,572,303...100,585,801
Ensembl chr15:100,572,302...100,585,802
JBrowse link
G Cfap20 cilia and flagella associated protein 20 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 8:96,146,867...96,161,716
Ensembl chr 8:96,146,877...96,161,497
JBrowse link
G Cfh complement component factor h ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:140,013,593...140,111,149
Ensembl chr 1:140,012,446...140,111,502
JBrowse link
G Chrm3 cholinergic receptor, muscarinic 3, cardiac ISO CTD Direct Evidence: marker/mechanism CTD PMID:20197374 NCBI chr13:9,925,522...10,411,131
Ensembl chr13:9,925,522...10,410,883
JBrowse link
G Ckb creatine kinase, brain ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr12:111,635,789...111,638,772
Ensembl chr12:111,635,795...111,638,772
JBrowse link
G Clu clusterin ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr14:66,205,932...66,218,997
Ensembl chr14:66,205,932...66,218,996
JBrowse link
G Col14a1 collagen, type XIV, alpha 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr15:55,171,040...55,384,199
Ensembl chr15:55,171,146...55,384,199
JBrowse link
G Col3a1 collagen, type III, alpha 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16679477 NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
JBrowse link
G Comt catechol-O-methyltransferase ISO protein:decreased expression:liver RGD PMID:21138988 RGD:7241599 NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602
JBrowse link
G Coq9 coenzyme Q9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 8:95,565,041...95,581,523
Ensembl chr 8:95,564,949...95,581,523
JBrowse link
G Cp ceruloplasmin ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:20,011,097...20,063,914
Ensembl chr 3:20,011,218...20,063,309
JBrowse link
G Cpb2 carboxypeptidase B2 (plasma) ISO mRNA,protein:increased expression,increased activity:liver,plasma RGD PMID:19386599 RGD:7243112 NCBI chr14:75,479,727...75,520,995
Ensembl chr14:75,479,727...75,520,995
JBrowse link
G Cps1 carbamoyl-phosphate synthetase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:67,151,294...67,270,426
Ensembl chr 1:67,162,185...67,270,418
JBrowse link
G Crp C-reactive protein, pentraxin-related ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
JBrowse link
G Csf3 colony stimulating factor 3 (granulocyte) ISO CTD Direct Evidence: therapeutic CTD PMID:20005281 NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
JBrowse link
G Ctnnb1 catenin (cadherin associated protein), beta 1 ISO CTD Direct Evidence: therapeutic CTD PMID:19679878 NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
JBrowse link
G Ctse cathepsin E ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:131,566,052...131,603,245
Ensembl chr 1:131,566,044...131,603,243
JBrowse link
G Cxcl1 chemokine (C-X-C motif) ligand 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16118408 NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
JBrowse link
G Cxcl10 chemokine (C-X-C motif) ligand 10 ISO CTD Direct Evidence: therapeutic CTD PMID:11739529 NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
JBrowse link
G Cxcl3 chemokine (C-X-C motif) ligand 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16118408 NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:33814510 NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28762043 NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:33814510 NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
JBrowse link
G Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 IEP mRNA, protein:decreased expression:kidney (mouse) RGD PMID:26476181 RGD:25671412 NCBI chr10:126,884,115...126,891,897
Ensembl chr10:126,884,119...126,888,875
JBrowse link
G Cyp2a5 cytochrome P450, family 2, subfamily a, polypeptide 5 EXP
ISO
CTD Direct Evidence: therapeutic
CTD Direct Evidence: marker/mechanism
CTD PMID:21741958 PMID:23628428 NCBI chr 7:26,534,764...26,542,689
Ensembl chr 7:26,534,730...26,542,973
JBrowse link
G Cyp2b10 cytochrome P450, family 2, subfamily b, polypeptide 10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28762043 PMID:33814510 NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
JBrowse link
G Cyp2c38 cytochrome P450, family 2, subfamily c, polypeptide 38 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12963435 PMID:28762043 NCBI chr19:39,378,000...39,451,547
Ensembl chr19:39,378,000...39,451,519
JBrowse link
G Cyp2c52-ps cytochrome P450, family 2, subfamily c, polypeptide 52, pseudogene ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr19:38,965,106...38,992,071
Ensembl chr19:38,965,091...38,991,733
JBrowse link
G Cyp2c65 cytochrome P450, family 2, subfamily c, polypeptide 65 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14971821 PMID:21741958 PMID:28762043 PMID:33814510 NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
JBrowse link
G Cyp2c66 cytochrome P450, family 2, subfamily c, polypeptide 66 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14971821 PMID:21741958 PMID:28762043 PMID:33814510 NCBI chr19:39,102,342...39,175,200
Ensembl chr19:39,102,342...39,175,516
JBrowse link
G Cyp2d22 cytochrome P450, family 2, subfamily d, polypeptide 22 ISO DNA:hypermethylation:promoter RGD PMID:27490558 RGD:14700879 NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 treatment ISO
IMP
CTD Direct Evidence: marker/mechanism
DNA:hypermethylation:promoter
associated with Endotoxemia
CTD
RGD
PMID:12668988 PMID:16770646 PMID:21741958 PMID:28762043 PMID:27960551 More... RGD:14700901, RGD:14700879, RGD:14700878, RGD:14700873, RGD:14700872 NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
JBrowse link
G Cyp8b1 cytochrome P450, family 8, subfamily b, polypeptide 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25448281 NCBI chr 9:121,743,422...121,745,371
Ensembl chr 9:121,743,422...121,745,371
JBrowse link
G Dbt dihydrolipoamide branched chain transacylase E2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 3:116,306,719...116,343,630
Ensembl chr 3:116,306,719...116,343,630
JBrowse link
G Ddb1 damage specific DNA binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr19:10,582,932...10,607,192
Ensembl chr19:10,582,691...10,607,183
JBrowse link
G Dgat2 diacylglycerol O-acyltransferase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr 7:98,802,870...98,831,920
Ensembl chr 7:98,802,865...98,831,926
JBrowse link
G Dhfr dihydrofolate reductase ISO CTD Direct Evidence: marker/mechanism CTD PMID:19648163 NCBI chr13:92,491,291...92,525,561
Ensembl chr13:92,491,234...92,525,561
JBrowse link
G Dhrs7 dehydrogenase/reductase (SDR family) member 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr12:72,697,127...72,711,678
Ensembl chr12:72,697,127...72,711,683
JBrowse link
G Dlat dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase complex) ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 9:50,545,933...50,571,080
Ensembl chr 9:50,545,933...50,571,080
JBrowse link
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr12:44,252,680...44,256,851
Ensembl chr12:44,252,342...44,257,109
JBrowse link
G Dnajc12 DnaJ heat shock protein family (Hsp40) member C12 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr10:63,218,222...63,244,619
Ensembl chr10:63,218,222...63,246,355
JBrowse link
G Dsc2 desmocollin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr18:20,163,690...20,192,611
Ensembl chr18:20,163,690...20,192,611
JBrowse link
G E2f1 E2F transcription factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30515189 NCBI chr 2:154,401,320...154,411,812
Ensembl chr 2:154,401,327...154,411,812
JBrowse link
G Echdc1 enoyl Coenzyme A hydratase domain containing 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr10:29,174,140...29,222,657
Ensembl chr10:29,189,162...29,223,465
JBrowse link
G Echs1 enoyl Coenzyme A hydratase, short chain, 1, mitochondrial ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 7:139,685,623...139,696,334
Ensembl chr 7:139,685,623...139,696,389
JBrowse link
G Edem1 ER degradation enhancer, mannosidase alpha-like 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 6:108,800,984...108,836,317
Ensembl chr 6:108,805,602...108,836,317
JBrowse link
G Eif2ak1 eukaryotic translation initiation factor 2 alpha kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25411909 NCBI chr 5:143,803,530...143,839,535
Ensembl chr 5:143,803,543...143,841,069
JBrowse link
G Eif4ebp2 eukaryotic translation initiation factor 4E binding protein 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr10:61,268,276...61,288,448
Ensembl chr10:61,264,270...61,288,440
JBrowse link
G Endog endonuclease G ISO protein:decreased expression:mitochondrion: RGD PMID:22509279 RGD:9685364 NCBI chr 2:30,061,421...30,064,081
Ensembl chr 2:30,061,505...30,064,081
JBrowse link
G Eng endoglin ISO protein:increased expression:liver (rat) RGD PMID:21146604 RGD:7257529 NCBI chr 2:32,536,607...32,572,681
Ensembl chr 2:32,536,607...32,572,681
JBrowse link
G Eno1 enolase 1, alpha non-neuron ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 PMID:25231249 NCBI chr 4:150,321,165...150,333,336
Ensembl chr 4:150,321,178...150,333,336
JBrowse link
G Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 ISO protein:increased activity:serum: RGD PMID:17850827 RGD:9685426 NCBI chr15:54,702,297...54,816,284
Ensembl chr15:54,702,297...54,816,288
JBrowse link
G Ephx1 epoxide hydrolase 1, microsomal ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
JBrowse link
G Erlec1 endoplasmic reticulum lectin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr11:30,812,794...30,904,385
Ensembl chr11:30,880,774...30,904,335
JBrowse link
G Ern1 endoplasmic reticulum (ER) to nucleus signalling 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30538632 NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678
JBrowse link
G F13a1 coagulation factor XIII, A1 subunit IMP RGD PMID:22019897 RGD:11041813 NCBI chr13:37,051,150...37,234,220
Ensembl chr13:37,051,152...37,234,220
JBrowse link
G F2rl3 coagulation factor II (thrombin) receptor-like 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20974703 NCBI chr 8:73,488,287...73,490,526
Ensembl chr 8:73,488,508...73,490,502
JBrowse link
G F3 coagulation factor III ISO CTD Direct Evidence: marker/mechanism CTD PMID:22407844 NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
JBrowse link
G Fadd Fas (TNFRSF6)-associated via death domain treatment ISO RGD PMID:26062544 PMID:25447754 RGD:11341803, RGD:10053709 NCBI chr 7:144,132,060...144,136,178
Ensembl chr 7:144,131,055...144,136,200
JBrowse link
G Fads1 fatty acid desaturase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr19:10,160,245...10,174,238
Ensembl chr19:10,160,252...10,174,241
JBrowse link
G Fads2 fatty acid desaturase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr19:10,040,129...10,078,867
Ensembl chr19:10,040,129...10,079,110
JBrowse link
G Fas Fas (TNF receptor superfamily member 6) ISO protein:increased expression:liver (rat) RGD PMID:16831245 RGD:8662853 NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
JBrowse link
G Fasn fatty acid synthase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr11:120,696,784...120,715,992
Ensembl chr11:120,696,672...120,715,373
JBrowse link
G Fcmr Fc fragment of IgM receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:130,793,514...130,808,527
Ensembl chr 1:130,793,406...130,808,528
JBrowse link
G Fga fibrinogen alpha chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:20974703 NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934
JBrowse link
G Fgf21 fibroblast growth factor 21 severity ISO mRNA:increased expression:liver (rat) RGD PMID:29883717 RGD:15045603 NCBI chr 7:45,263,314...45,264,914
Ensembl chr 7:45,263,310...45,264,914
JBrowse link
G Flt1 FMS-like tyrosine kinase 1 ISO CTD Direct Evidence: therapeutic CTD PMID:21135413 NCBI chr 5:147,498,414...147,663,419
Ensembl chr 5:147,498,414...147,662,821
JBrowse link
G Fmo3 flavin containing monooxygenase 3 ISO CTD Direct Evidence: therapeutic CTD PMID:24973094 NCBI chr 1:162,781,368...162,812,097
Ensembl chr 1:162,781,369...162,812,097
JBrowse link
G Ftl1 ferritin light polypeptide 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 7:45,107,368...45,109,310
Ensembl chr 7:45,107,368...45,109,308
JBrowse link
G G6pc glucose-6-phosphatase, catalytic IEP mRNA:decreased expression:liver (mouse) RGD PMID:28189721 RGD:14695531 NCBI chr11:101,258,542...101,268,729
Ensembl chr11:101,258,387...101,268,729
JBrowse link
G G6pdx glucose-6-phosphate dehydrogenase X-linked treatment ISO RGD PMID:21864513 RGD:10449168 NCBI chr  X:73,453,089...73,472,486
Ensembl chr  X:73,453,089...73,472,800
JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible 45 alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441
JBrowse link
G Ganab alpha glucosidase 2 alpha neutral subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr19:8,875,421...8,894,106
Ensembl chr19:8,875,435...8,894,036
JBrowse link
G Gc vitamin D binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757
JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:19481141 PMID:17573345 RGD:10402383 NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
JBrowse link
G Gclm glutamate-cysteine ligase, modifier subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 3:122,039,206...122,060,864
Ensembl chr 3:122,039,206...122,064,381
JBrowse link
G Gda guanine deaminase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr19:21,368,671...21,450,025
Ensembl chr19:21,368,671...21,450,809
JBrowse link
G Gdi1 guanosine diphosphate (GDP) dissociation inhibitor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr  X:73,348,618...73,355,473
Ensembl chr  X:73,348,604...73,355,468
JBrowse link
G Gfer growth factor, augmenter of liver regeneration treatment ISO RGD PMID:22033404 PMID:15968720 RGD:9685722, RGD:9685727 NCBI chr17:24,912,163...24,916,133
Ensembl chr17:24,912,161...24,915,130
JBrowse link
G Ggh gamma-glutamyl hydrolase ISO CTD Direct Evidence: marker/mechanism CTD PMID:21219404 NCBI chr 4:20,041,963...20,066,111
Ensembl chr 4:20,042,052...20,066,750
JBrowse link
G Ggt1 gamma-glutamyltransferase 1 ISO RGD PMID:10934156 RGD:14701049 NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034
JBrowse link
G Glud1 glutamate dehydrogenase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:33483742 NCBI chr14:34,032,684...34,066,990
Ensembl chr14:34,032,684...34,067,222
JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1, soluble ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
JBrowse link
G Gpd1 glycerol-3-phosphate dehydrogenase 1 (soluble) ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr15:99,615,468...99,622,895
Ensembl chr15:99,615,396...99,622,886
JBrowse link
G Gpt glutamic pyruvic transaminase, soluble treatment ISO
IEP
CTD Direct Evidence: marker/mechanism
protein:increased expression, activity:serum:
CTD
RGD
PMID:145039 PMID:19481104 PMID:19085960 PMID:19085960 PMID:27293452 More... RGD:14975249, RGD:14975249, RGD:14975168, RGD:14975166, RGD:14975162 NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
JBrowse link
G Gpt2 glutamic pyruvate transaminase (alanine aminotransferase) 2 ISO
IEP
protein:increased expression, activity:serum: RGD PMID:19085960 PMID:19085960 RGD:14975249, RGD:14975249 NCBI chr 8:86,219,090...86,255,531
Ensembl chr 8:86,219,205...86,254,189
JBrowse link
G Grk4 G protein-coupled receptor kinase 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 5:34,817,641...34,912,649
Ensembl chr 5:34,817,723...34,912,649
JBrowse link
G Gsn gelsolin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 2:35,146,371...35,197,914
Ensembl chr 2:35,146,392...35,197,904
JBrowse link
G Gsr glutathione reductase treatment ISO mRNA, protein:increased expression:liver
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:25226513 PMID:28069987 PMID:23554813 PMID:24154663 RGD:7257532, RGD:10401878 NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
JBrowse link
G Gstm1 glutathione S-transferase, mu 1 no_association ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:liver
CTD
RGD
PMID:17465707 PMID:18666253 PMID:25501156 PMID:24465778 PMID:24903797 More... RGD:14700970, RGD:14700959, RGD:14700941, RGD:14700937, RGD:7241599 NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
JBrowse link
G Gstm2 glutathione S-transferase, mu 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 3:107,889,018...107,893,736
Ensembl chr 3:107,889,018...107,893,769
JBrowse link
G Gstm4 glutathione S-transferase, mu 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:107,937,887...107,952,495
Ensembl chr 3:107,947,724...107,952,210
JBrowse link
G Gstm5 glutathione S-transferase, mu 5 ISO CTD Direct Evidence: therapeutic CTD PMID:25743375 NCBI chr 3:107,803,170...107,806,001
Ensembl chr 3:107,803,137...107,806,002
JBrowse link
G Gsto1 glutathione S-transferase omega 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr19:47,843,412...47,853,229
Ensembl chr19:47,843,409...47,853,229
JBrowse link
G Gstp1 glutathione S-transferase, pi 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 PMID:25226513 NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
JBrowse link
G Gstt1 glutathione S-transferase, theta 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18397238 PMID:18666253 PMID:25226513 NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
JBrowse link
G Gulo gulonolactone (L-) oxidase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr14:66,224,235...66,246,703
Ensembl chr14:66,224,235...66,246,656
JBrowse link
G H19 H19, imprinted maternally expressed transcript ISO CTD Direct Evidence: marker/mechanism CTD PMID:30515189 NCBI chr 7:142,129,267...142,131,883
Ensembl chr 7:142,129,266...142,131,880
JBrowse link
G H2-Aa histocompatibility 2, class II antigen A, alpha susceptibility ISO DNA:polymorphism: :HLA-DQA1*0102(human)
associated with tuberculosis;DNA:polymorphism: :HLA-DQA1*0102(human)
RGD PMID:20639878 PMID:12359646 RGD:14398844, RGD:14401573 NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797
JBrowse link
G H2-Ab1 histocompatibility 2, class II antigen A, beta 1 susceptibility ISO CTD Direct Evidence: marker/mechanism
DNA:polymorphism: :HLA-DQB1*05(human)
DNA:polymorphism, haplotype
CTD
RGD
PMID:21570397 PMID:25250564 PMID:26959717 RGD:36174016, RGD:11573514 NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
JBrowse link
G H2-Eb1 histocompatibility 2, class II antigen E beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:21570397 NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648
JBrowse link
G H2-M2 histocompatibility 2, M region locus 2 ISO CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Drug-induced liver injury due to flucloxacillin
CTD
ClinVar
PMID:11888582 PMID:11943262 PMID:12462283 PMID:15024131 PMID:15247624 More... NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443
JBrowse link
G H2-Q1 histocompatibility 2, Q region locus 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21570397 PMID:28043905 NCBI chr17:35,539,503...35,547,118
Ensembl chr17:35,539,381...35,544,075
JBrowse link
G H2ax H2A.X variant histone treatment ISO RGD PMID:23265463 RGD:8693741 NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
JBrowse link
G Hacl1 2-hydroxyacyl-CoA lyase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr14:31,329,183...31,364,201
Ensembl chr14:31,320,687...31,363,243
JBrowse link
G Hadha hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 5:30,324,421...30,359,978
Ensembl chr 5:30,323,302...30,360,160
JBrowse link
G Hamp hepcidin antimicrobial peptide ISO mRNA:increased expression:hepatocyte RGD PMID:24373749 RGD:11041724 NCBI chr 7:30,641,793...30,643,454
Ensembl chr 7:30,641,793...30,643,457
JBrowse link
G Hao2 hydroxyacid oxidase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:98,781,835...98,802,692
Ensembl chr 3:98,781,837...98,800,555
JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
JBrowse link
G Hba-a1 hemoglobin alpha, adult chain 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr11:32,233,672...32,234,486
Ensembl chr11:32,233,511...32,234,465
JBrowse link
G Hmgb1 high mobility group box 1 treatment ISO
IEP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:19783637 PMID:29091898 RGD:15090820 NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
JBrowse link
G Hmox1 heme oxygenase 1 treatment ISO
IEP
CTD Direct Evidence: marker/mechanism|therapeutic CTD
RGD
PMID:18227147 PMID:22688006 PMID:22886620 PMID:29091898 RGD:10762620, RGD:15090820 NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
JBrowse link
G Hpd 4-hydroxyphenylpyruvic acid dioxygenase ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 PMID:22872058 NCBI chr 5:123,309,870...123,320,786
Ensembl chr 5:123,309,870...123,320,790
JBrowse link
G Hprt hypoxanthine guanine phosphoribosyl transferase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr  X:52,076,955...52,110,537
Ensembl chr  X:52,077,014...52,110,536
JBrowse link
G Hpx hemopexin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 7:105,240,818...105,249,323
Ensembl chr 7:105,240,820...105,249,344
JBrowse link
G Hrh2 histamine receptor H2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22926047 NCBI chr13:54,345,990...54,390,201
Ensembl chr13:54,346,148...54,390,199
JBrowse link
G Hspa5 heat shock protein 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
JBrowse link
G Hspa8 heat shock protein 8 ISO protein:altered localization:liver (rat) RGD PMID:12376827 RGD:10059389 NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383
JBrowse link
G Icam1 intercellular adhesion molecule 1 treatment IEP RGD PMID:29091898 RGD:15090820 NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
JBrowse link
G Idh2 isocitrate dehydrogenase 2 (NADP+), mitochondrial severity IMP RGD PMID:31121248 RGD:14985250 NCBI chr 7:79,744,594...79,768,356
Ensembl chr 7:79,744,594...79,765,140
JBrowse link
G Ido2 indoleamine 2,3-dioxygenase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:32289347 NCBI chr 8:25,021,908...25,066,430
Ensembl chr 8:25,021,908...25,066,349
JBrowse link
G Ifng interferon gamma ISO
IEP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:12153990 PMID:21245496 PMID:30013034 RGD:14975100 NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
JBrowse link
G Igf1 insulin-like growth factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23639586 PMID:25226513 NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
JBrowse link
G Il11 interleukin 11 ISO CTD Direct Evidence: therapeutic CTD PMID:11421492 NCBI chr 7:4,775,372...4,785,877
Ensembl chr 7:4,775,372...4,785,858
JBrowse link
G Il17a interleukin 17A ISO CTD Direct Evidence: marker/mechanism CTD PMID:19633216 PMID:24949944 NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
JBrowse link
G Il18 interleukin 18 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19164858 NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
JBrowse link
G Il1a interleukin 1 alpha ISO CTD Direct Evidence: therapeutic CTD PMID:8218930 NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
JBrowse link
G Il1b interleukin 1 beta treatment ISO
IEP
CTD Direct Evidence: marker/mechanism|therapeutic CTD
RGD
PMID:19164858 PMID:28138970 PMID:23102243 PMID:29091898 PMID:31342809 More... RGD:7204421, RGD:15090820, RGD:15036799, RGD:14975281, RGD:13793380 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
JBrowse link
G Il1r2 interleukin 1 receptor, type II ISO CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr 1:40,123,872...40,164,390
Ensembl chr 1:40,113,239...40,164,391
JBrowse link
G Il22b interleukin 22B ISO CTD Direct Evidence: therapeutic CTD PMID:15122762 PMID:16212920 PMID:23375450 NCBI chr10:118,125,534...118,130,943
Ensembl chr10:118,125,534...118,130,943
JBrowse link
G Il4 interleukin 4 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:21094227 PMID:21735453 PMID:22107450 NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
JBrowse link
G Il6 interleukin 6 treatment ISO
IEP
CTD Direct Evidence: therapeutic CTD
RGD
PMID:7532385 PMID:15763341 PMID:29091898 RGD:15090820 NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
JBrowse link
G Immt inner membrane protein, mitochondrial ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:71,806,200...71,852,250
Ensembl chr 6:71,808,315...71,854,372
JBrowse link
G Irak1 interleukin-1 receptor-associated kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr  X:73,057,520...73,067,527
Ensembl chr  X:73,057,520...73,067,524
JBrowse link
G Itpr1 inositol 1,4,5-trisphosphate receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 6:108,190,044...108,528,077
Ensembl chr 6:108,190,057...108,528,070
JBrowse link
G Jund jun D proto-oncogene ISO CTD Direct Evidence: marker/mechanism CTD PMID:30515189 NCBI chr 8:71,150,389...71,153,265
Ensembl chr 8:71,151,599...71,153,265
JBrowse link
G Keap1 kelch-like ECH-associated protein 1 IMP RGD PMID:18417483 RGD:6893370 NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
JBrowse link
G Kitl kit ligand EXP CTD Direct Evidence: therapeutic CTD PMID:12594235 NCBI chr10:99,851,477...99,936,278
Ensembl chr10:99,851,492...99,936,278
JBrowse link
G Kng2 kininogen 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20362651 PMID:30685357 NCBI chr16:22,804,602...22,847,851
Ensembl chr16:22,804,604...22,848,232
JBrowse link
G Krt18 keratin 18 IEP
ISO
mRNA, protein:increased expression:liver (mouse)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:19783637 PMID:33483742 PMID:17340120 RGD:18337498 NCBI chr15:101,936,651...101,940,461
Ensembl chr15:101,936,615...101,940,462
JBrowse link
G Krt8 keratin 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr15:101,905,146...101,912,777
Ensembl chr15:101,905,133...101,912,917
JBrowse link
G Lap3 leucine aminopeptidase 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 5:45,650,716...45,670,033
Ensembl chr 5:45,650,716...45,670,033
JBrowse link
G Lbp lipopolysaccharide binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 2:158,148,413...158,174,772
Ensembl chr 2:158,148,413...158,174,772
JBrowse link
G Lcn2 lipocalin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20362651 PMID:20623750 NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
JBrowse link
G Lgals3 lectin, galactose binding, soluble 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22461450 NCBI chr14:47,611,317...47,623,624
Ensembl chr14:47,605,208...47,623,617
JBrowse link
G Lpl lipoprotein lipase treatment ISO RGD PMID:27071702 RGD:13794380 NCBI chr 8:69,333,207...69,359,584
Ensembl chr 8:69,333,143...69,360,100
JBrowse link
G Lrat lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase) ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:82,799,889...82,811,281
Ensembl chr 3:82,799,886...82,811,280
JBrowse link
G Ltb4r1 leukotriene B4 receptor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28487374 NCBI chr14:56,003,419...56,005,949
Ensembl chr14:56,003,419...56,005,951
JBrowse link
G Ltf lactotransferrin ISO CTD Direct Evidence: therapeutic CTD PMID:16141546 NCBI chr 9:110,848,360...110,871,834
Ensembl chr 9:110,848,339...110,871,835
JBrowse link
G Malat1 metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA) ISO CTD Direct Evidence: marker/mechanism CTD PMID:30515189 NCBI chr19:5,845,718...5,852,700
Ensembl chr19:5,845,718...5,852,700
JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 8:122,317,177...122,325,499
Ensembl chr 8:122,317,100...122,325,499
JBrowse link
G Map3k5 mitogen-activated protein kinase kinase kinase 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18700144 NCBI chr10:19,809,847...20,018,496
Ensembl chr10:19,810,218...20,018,499
JBrowse link
G Mat1a methionine adenosyltransferase I, alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr14:40,826,969...40,846,385
Ensembl chr14:40,826,992...40,846,369
JBrowse link
G Mccc1 methylcrotonoyl-Coenzyme A carboxylase 1 (alpha) ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 3:36,009,584...36,054,843
Ensembl chr 3:36,013,461...36,054,827
JBrowse link
G Mdh1 malate dehydrogenase 1, NAD (soluble) ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr11:21,506,692...21,521,934
Ensembl chr11:21,506,692...21,522,367
JBrowse link
G Me1 malic enzyme 1, NADP(+)-dependent, cytosolic ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 9:86,463,416...86,577,967
Ensembl chr 9:86,463,424...86,578,006
JBrowse link
G Med1 mediator complex subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16109766 NCBI chr11:98,042,980...98,084,121
Ensembl chr11:98,042,980...98,084,119
JBrowse link
G Mir100 microRNA 100 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 9:41,442,721...41,442,800
Ensembl chr 9:41,442,721...41,442,800
JBrowse link
G Mir103-1 microRNA 103-1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr11:35,673,223...35,673,308
Ensembl chr11:35,673,223...35,673,308
JBrowse link
G Mir106b microRNA 106b IEP
IDA
miRNA:decreased expression:liver (rat)
DNA:hypermethylation:promoter
RGD PMID:29554950 PMID:29554950 RGD:15042854, RGD:15042854 NCBI chr 5:138,163,999...138,164,080
Ensembl chr 5:138,163,999...138,164,080
JBrowse link
G Mir107 microRNA 107 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25359176 PMID:28545106 NCBI chr19:34,798,087...34,798,173
Ensembl chr19:34,798,087...34,798,173
JBrowse link
G Mir10a microRNA 10a ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr11:96,207,991...96,208,100
Ensembl chr11:96,207,991...96,208,100
JBrowse link
G Mir10b microRNA 10b ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 2:74,556,414...74,556,481
Ensembl chr 2:74,556,414...74,556,481
JBrowse link
G Mir122 microRNA 122 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22045675 PMID:22363424 PMID:25359176 PMID:25527335 PMID:26489516 More... NCBI chr18:65,381,932...65,381,997
Ensembl chr18:65,381,932...65,381,997
JBrowse link
G Mir1247 microRNA 1247 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr12:110,244,482...110,244,563
Ensembl chr12:110,244,482...110,244,563
JBrowse link
G Mir1249 microRNA 1249 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr15:84,835,727...84,835,824
Ensembl chr15:84,835,727...84,835,824
JBrowse link
G Mir125b-1 microRNA 125b-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 9:41,493,222...41,493,298
Ensembl chr 9:41,493,222...41,493,298
JBrowse link
G Mir125b-2 microRNA 125b-2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr16:77,443,161...77,443,231
Ensembl chr16:77,443,161...77,443,231
JBrowse link
G Mir1291 microRNA 1291 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr15:98,417,643...98,417,759
Ensembl chr15:98,417,643...98,417,759
JBrowse link
G Mir1306 microRNA 1306 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr16:18,102,103...18,102,181
Ensembl chr16:18,102,103...18,102,181
JBrowse link
G Mir130a microRNA 130a ISO CTD Direct Evidence: marker/mechanism CTD PMID:25359176 PMID:28545106 NCBI chr 2:84,571,459...84,571,522
Ensembl chr 2:84,571,459...84,571,522
JBrowse link
G Mir130b microRNA 130b ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr16:16,941,925...16,942,006
Ensembl chr16:16,941,925...16,942,006
JBrowse link
G Mir132 microRNA 132 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr11:75,064,508...75,064,573
Ensembl chr11:75,064,508...75,064,573
JBrowse link
G Mir141 microRNA 141 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 PMID:28545106 NCBI chr 6:124,694,877...124,694,948
Ensembl chr 6:124,694,877...124,694,948
JBrowse link
G Mir142 microRNA 142 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:87,647,690...87,647,753
Ensembl chr11:87,647,690...87,647,753
JBrowse link
G Mir143 microRNA 143 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30125006 NCBI chr18:61,782,267...61,782,329
Ensembl chr18:61,782,267...61,782,329
JBrowse link
G Mir148a microRNA 148a ISO CTD Direct Evidence: marker/mechanism CTD PMID:25359176 PMID:28545106 NCBI chr 6:51,246,792...51,246,890
Ensembl chr 6:51,246,792...51,246,890
JBrowse link
G Mir149 microRNA 149 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 1:92,778,100...92,778,165
Ensembl chr 1:92,778,100...92,778,165
JBrowse link
G Mir150 microRNA 150 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 7:44,771,181...44,771,245
Ensembl chr 7:44,771,181...44,771,245
JBrowse link
G Mir152 microRNA 152 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:96,741,219...96,741,291
Ensembl chr11:96,741,219...96,741,291
JBrowse link
G Mir155 microRNA 155 treatment IMP
IDA
RGD PMID:29420849 PMID:26867493 PMID:27673475 RGD:21409750, RGD:25671474, RGD:25671463 NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
JBrowse link
G Mir17 microRNA 17 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr14:115,281,103...115,281,186
Ensembl chr14:115,281,103...115,281,186
JBrowse link
G Mir18 microRNA 18 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr14:115,281,283...115,281,378
Ensembl chr14:115,281,283...115,281,378
JBrowse link
G Mir181c microRNA 181c ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 8:84,905,502...84,905,590
Ensembl chr 8:84,905,502...84,905,590
JBrowse link
G Mir188 microRNA 188 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:7,114,228...7,114,295
Ensembl chr  X:7,114,228...7,114,295
JBrowse link
G Mir191 microRNA 191 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 9:108,445,518...108,445,591
Ensembl chr 9:108,445,518...108,445,591
JBrowse link
G Mir192 microRNA 192 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22045675 PMID:25359176 PMID:28483554 PMID:28545106 NCBI chr19:6,314,874...6,314,962
Ensembl chr19:6,314,874...6,314,962
JBrowse link
G Mir193a microRNA 193a ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:79,602,795...79,602,860
Ensembl chr11:79,602,795...79,602,860
JBrowse link
G Mir193b microRNA 193b ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr16:13,267,387...13,267,465
Ensembl chr16:13,267,387...13,267,465
JBrowse link
G Mir194-1 microRNA 194-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28844483 NCBI chr 1:185,045,516...185,045,582
Ensembl chr 1:185,045,516...185,045,582
JBrowse link
G Mir19a microRNA 19a ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr14:115,281,432...115,281,513
Ensembl chr14:115,281,432...115,281,513
JBrowse link
G Mir1a-1 microRNA 1a-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30125006 NCBI chr 2:180,030,841...180,030,917
Ensembl chr 2:180,030,841...180,030,917
JBrowse link
G Mir200c microRNA 200c ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 6:124,695,285...124,695,353
Ensembl chr 6:124,695,285...124,695,353
JBrowse link
G Mir203 microRNA 203 EXP CTD Direct Evidence: therapeutic CTD PMID:32659284 NCBI chr12:112,097,314...112,097,389
Ensembl chr12:112,097,314...112,097,389
JBrowse link
G Mir210 microRNA 210 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 7:140,801,297...140,801,406
Ensembl chr 7:140,801,297...140,801,406
JBrowse link
G Mir217 microRNA 217 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr11:28,713,728...28,713,835
Ensembl chr11:28,713,728...28,713,835
JBrowse link
G Mir218-1 microRNA 218-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 PMID:30125006 NCBI chr 5:48,381,284...48,381,393
Ensembl chr 5:48,381,284...48,381,393
JBrowse link
G Mir21a microRNA 21a ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984
JBrowse link
G Mir22 microRNA 22 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25359176 PMID:28545106 NCBI chr11:75,354,542...75,354,636
Ensembl chr11:75,354,542...75,354,636
JBrowse link
G Mir221 microRNA 221 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:19,012,533...19,012,627
Ensembl chr  X:19,012,533...19,012,627
JBrowse link
G Mir222 microRNA 222 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:19,013,132...19,013,210
Ensembl chr  X:19,013,132...19,013,210
JBrowse link
G Mir223 microRNA 223 IEP RNA:increased expression:serum,liver RGD PMID:28646120 RGD:21408574 NCBI chr  X:95,286,423...95,286,532
Ensembl chr  X:95,286,423...95,286,532
JBrowse link
G Mir23a microRNA 23a ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 8:84,935,147...84,935,221
Ensembl chr 8:84,935,147...84,935,221
JBrowse link
G Mir23b microRNA 23b ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr13:63,448,298...63,448,371
Ensembl chr13:63,448,298...63,448,371
JBrowse link
G Mir27b microRNA 27b ISO CTD Direct Evidence: marker/mechanism CTD PMID:25359176 PMID:28545106 NCBI chr13:63,448,526...63,448,598
Ensembl chr13:63,448,526...63,448,598
JBrowse link
G Mir29b-2 microRNA 29b-2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 1:194,719,348...194,719,428
Ensembl chr 1:194,719,348...194,719,428
JBrowse link
G Mir29c microRNA 29c ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 PMID:30515189 NCBI chr 1:194,719,855...194,719,942
Ensembl chr 1:194,719,855...194,719,942
JBrowse link
G Mir301 microRNA 301 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:87,003,830...87,003,915
Ensembl chr11:87,003,830...87,003,915
JBrowse link
G Mir30a microRNA 30a ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 PMID:25359176 PMID:28545106 NCBI chr 1:23,311,350...23,311,420
Ensembl chr 1:23,311,350...23,311,420
JBrowse link
G Mir30b microRNA 30b ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr15:68,209,264...68,209,359
Ensembl chr15:68,209,264...68,209,359
JBrowse link
G Mir30c-1 microRNA 30c-1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 4:120,626,731...120,626,819
Ensembl chr 4:120,626,731...120,626,819
JBrowse link
G Mir320 microRNA 320 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 PMID:30125006 NCBI chr14:70,680,950...70,681,031
Ensembl chr14:70,680,950...70,681,031
JBrowse link
G Mir327 microRNA 327 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr14:45,184,900...45,184,968
Ensembl chr14:45,184,900...45,184,968
JBrowse link
G Mir328 microRNA 328 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 8:106,034,996...106,035,092
Ensembl chr 8:106,034,996...106,035,092
JBrowse link
G Mir335 microRNA 335 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 6:30,741,298...30,741,395
Ensembl chr 6:30,741,298...30,741,395
JBrowse link
G Mir337 microRNA 337 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr12:109,552,223...109,552,319
Ensembl chr12:109,552,223...109,552,319
JBrowse link
G Mir338 microRNA 338 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:119,905,591...119,905,688
Ensembl chr11:119,905,591...119,905,688
JBrowse link
G Mir342 microRNA 342 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr12:108,624,879...108,624,977
Ensembl chr12:108,624,879...108,624,977
JBrowse link
G Mir345 microRNA 345 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr12:108,802,899...108,802,994
Ensembl chr12:108,802,899...108,802,994
JBrowse link
G Mir34a microRNA 34a ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 4:150,152,911...150,153,012
Ensembl chr 4:150,152,911...150,153,012
JBrowse link
G Mir34c microRNA 34c ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 9:51,014,334...51,014,410
Ensembl chr 9:51,014,334...51,014,410
JBrowse link
G Mir351 microRNA 351 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr  X:52,142,132...52,142,230
Ensembl chr  X:52,142,132...52,142,230
JBrowse link
G Mir361 microRNA 361 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:111,984,521...111,984,590
Ensembl chr  X:111,984,521...111,984,590
JBrowse link
G Mir362 microRNA 362 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:7,108,221...7,108,285
Ensembl chr  X:7,108,221...7,108,285
JBrowse link
G Mir367 microRNA 367 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 3:127,339,382...127,339,456
Ensembl chr 3:127,339,382...127,339,456
JBrowse link
G Mir378a microRNA 378a ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr18:61,530,906...61,530,971
Ensembl chr18:61,530,906...61,530,971
JBrowse link
G Mir410 microRNA 410 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr12:109,710,149...109,710,229
Ensembl chr12:109,710,149...109,710,229
JBrowse link
G Mir421 microRNA 421 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:102,616,527...102,616,602
Ensembl chr  X:102,616,527...102,616,602
JBrowse link
G Mir423 microRNA 423 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:76,968,890...76,968,998
Ensembl chr11:76,968,890...76,968,998
JBrowse link
G Mir452 microRNA 452 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:71,305,830...71,305,914
Ensembl chr  X:71,305,830...71,305,914
JBrowse link
G Mir455 microRNA 455 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 4:63,175,088...63,175,169
Ensembl chr 4:63,175,088...63,175,169
JBrowse link
G Mir483 microRNA 483 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 7:142,208,661...142,208,733
Ensembl chr 7:142,208,661...142,208,733
JBrowse link
G Mir484 microRNA 484 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr16:13,977,490...13,977,556
Ensembl chr16:13,977,490...13,977,556
JBrowse link
G Mir497 microRNA 497 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:70,125,543...70,125,626
Ensembl chr11:70,125,543...70,125,626
JBrowse link
G Mir499 microRNA 499 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 2:155,464,800...155,464,878
Ensembl chr 2:155,464,800...155,464,878
JBrowse link
G Mir503 microRNA 503 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr  X:52,142,861...52,142,931
Ensembl chr  X:52,142,861...52,142,931
JBrowse link
G Mir505 microRNA 505 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:59,439,649...59,439,738
Ensembl chr  X:59,439,649...59,439,738
JBrowse link
G Mir5099 microRNA 5099 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28844483 NCBI chr12:36,866,204...36,866,277
Ensembl chr12:36,866,204...36,866,277
JBrowse link
G Mir532 microRNA 532 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:7,114,641...7,114,736
Ensembl chr  X:7,114,641...7,114,736
JBrowse link
G Mir574 microRNA 574 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 5:65,127,661...65,127,738
Ensembl chr 5:65,127,661...65,127,738
JBrowse link
G Mir592 microRNA 592 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 PMID:28545106 NCBI chr 6:27,936,654...27,936,749
Ensembl chr 6:27,936,654...27,936,749
JBrowse link
G Mir687 microRNA 687 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr14:73,444,203...73,444,291
Ensembl chr14:73,444,203...73,444,291
JBrowse link
G Mir697 microRNA 697 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 4:124,625,487...124,625,595
Ensembl chr 4:124,625,487...124,625,595
JBrowse link
G Mir704 microRNA 704 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 6:47,780,510...47,780,586
Ensembl chr 6:47,780,510...47,780,586
JBrowse link
G Mir744 microRNA 744 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 PMID:28545106 NCBI chr11:65,625,559...65,625,658
Ensembl chr11:65,625,559...65,625,658
JBrowse link
G Mir764 microRNA 764 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr  X:145,785,255...145,785,362
Ensembl chr  X:145,785,255...145,785,362
JBrowse link
G Mir877 microRNA 877 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27713024 NCBI chr17:36,271,622...36,271,706
Ensembl chr17:36,271,622...36,271,706
JBrowse link
G Mir879 microRNA 879 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 5:9,425,704...9,425,779
Ensembl chr 5:9,425,704...9,425,779
JBrowse link
G Mir93 microRNA 93 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 5:138,163,785...138,163,872
Ensembl chr 5:138,163,785...138,163,872
JBrowse link
G Mir99a microRNA 99a ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr16:77,395,824...77,395,888
Ensembl chr16:77,395,824...77,395,888
JBrowse link
G Mirlet7b microRNA let7b ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 PMID:30125006 NCBI chr15:85,591,520...85,591,604
Ensembl chr15:85,591,520...85,591,604
JBrowse link
G Mirlet7c-1 microRNA let7c-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr16:77,396,545...77,396,638
Ensembl chr16:77,396,545...77,396,638
JBrowse link
G Mirlet7d microRNA let7d ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr13:48,689,488...48,689,590
Ensembl chr13:48,689,488...48,689,590
JBrowse link
G Mirlet7g microRNA let7g ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 9:106,056,039...106,056,126
Ensembl chr 9:106,056,039...106,056,126
JBrowse link
G Mirlet7i microRNA let7i ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr10:122,821,545...122,821,629
Ensembl chr10:122,821,545...122,821,629
JBrowse link
G Mmp2 matrix metallopeptidase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15763341 NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
JBrowse link
G Mmp9 matrix metallopeptidase 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22507835 NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
JBrowse link
G Mst1 macrophage stimulating 1 (hepatocyte growth factor-like) ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 9:107,957,607...107,962,226
Ensembl chr 9:107,957,635...107,962,202
JBrowse link
G Mst1r macrophage stimulating 1 receptor (c-met-related tyrosine kinase) ISO CTD Direct Evidence: marker/mechanism CTD PMID:22575169 NCBI chr 9:107,784,057...107,797,582
Ensembl chr 9:107,784,072...107,797,582
JBrowse link
G mt-Nd6 NADH dehydrogenase 6, mitochondrial ISO mRNA:decreased expression:blood RGD PMID:20130021 RGD:8657129 NCBI chr MT:13,552...14,070
Ensembl chr MT:13,552...14,070
JBrowse link
G Mthfr methylenetetrahydrofolate reductase treatment ISO CTD Direct Evidence: marker/mechanism
associated with precursor lymphoblastic lymphoma/leukemia; DNA:SNP: :677C>T(human)
CTD
RGD
PMID:18551038 PMID:19648163 PMID:30545275 RGD:14696733 NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
JBrowse link
G Mtpn myotrophin ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:35,485,759...35,516,823
Ensembl chr 6:35,485,841...35,516,823
JBrowse link
G Myd88 myeloid differentiation primary response gene 88 ameliorates IMP RGD PMID:17615358 RGD:150521532 NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477
JBrowse link
G Nat2 N-acetyltransferase 2 (arylamine N-acetyltransferase) treatment ISO associated with Tuberculosis;DNA:haplotype: :
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:11915035 PMID:16799928 PMID:17950035 PMID:25693865 PMID:18023090 RGD:8552665 NCBI chr 8:67,947,527...67,955,296
Ensembl chr 8:67,947,510...67,955,236
JBrowse link
G Ndufs3 NADH:ubiquinone oxidoreductase core subunit S3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 2:90,724,971...90,735,065
Ensembl chr 2:90,724,978...90,735,171
JBrowse link
G Nfatc4 nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4 ISO CTD Direct Evidence: therapeutic CTD PMID:34192554 NCBI chr14:56,062,252...56,071,400
Ensembl chr14:56,060,601...56,071,400
JBrowse link
G Nfe2l2 nuclear factor, erythroid derived 2, like 2 treatment IMP
ISO
IEP
induced by methotrexate (CHEBI:44185), treated by ferulic acid (CHEBI:17620)
CTD Direct Evidence: therapeutic
CTD
RGD
PMID:22491424 PMID:22627062 PMID:24813929 PMID:26958860 PMID:30215777 More... RGD:6893370, RGD:21201308, RGD:21201305, RGD:21201283, RGD:21201280, RGD:15090820 NCBI chr 2:75,505,857...75,535,007
Ensembl chr 2:75,505,857...75,534,985
JBrowse link
G Nfkb1 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 treatment
susceptibility
IEP
ISO
associated with tuberculosis ;DNA:SNPs,haplotypes: 3'utr,5'utr: (rs78872571,rs4647992) (human) RGD PMID:29091898 PMID:31490979 RGD:15090820, RGD:40902984 NCBI chr 3:135,290,416...135,397,728
Ensembl chr 3:135,290,416...135,397,308
JBrowse link
G Nfxl1 nuclear transcription factor, X-box binding-like 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 5:72,670,647...72,717,078
Ensembl chr 5:72,670,644...72,717,027
JBrowse link
G Nme2 NME/NM23 nucleoside diphosphate kinase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:93,840,640...93,847,082
Ensembl chr11:93,840,640...93,847,085
JBrowse link
G Notch1 notch 1 ISO CTD Direct Evidence: therapeutic CTD PMID:30394310 NCBI chr 2:26,347,914...26,393,834
Ensembl chr 2:26,347,915...26,406,675
JBrowse link
G Nox4 NADPH oxidase 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 7:86,893,638...87,047,918
Ensembl chr 7:86,895,304...87,047,918
JBrowse link
G Nqo1 NAD(P)H dehydrogenase, quinone 1 treatment ISO
IEP
RGD PMID:28522909 PMID:29091898 PMID:28472605 RGD:13439737, RGD:15090820, RGD:13439739 NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
JBrowse link
G Nr0b2 nuclear receptor subfamily 0, group B, member 2 ISO CTD Direct Evidence: therapeutic CTD PMID:29943110 NCBI chr 4:133,280,687...133,283,997
Ensembl chr 4:133,280,687...133,283,847
JBrowse link
G Nr1d1 nuclear receptor subfamily 1, group D, member 1 treatment IDA RGD PMID:24497272 RGD:10448995 NCBI chr11:98,658,758...98,666,233
Ensembl chr11:98,658,758...98,666,159
JBrowse link
G Nr1h3 nuclear receptor subfamily 1, group H, member 3 ISO CTD Direct Evidence: therapeutic CTD PMID:17256725 NCBI chr 2:91,014,406...91,033,189
Ensembl chr 2:91,014,406...91,033,179
JBrowse link
G Nr1h4 nuclear receptor subfamily 1, group H, member 4 treatment
severity
ISO
IEP
IMP
CTD Direct Evidence: marker/mechanism
mRNA:decreased expression:liver (rat)
protein:decreased expression:liver (rat)
CTD
RGD
PMID:12875239 PMID:29091898 PMID:28827769 PMID:30068870 PMID:22711662 More... RGD:15090820, RGD:15045609, RGD:15042870, RGD:14701036, RGD:14701035 NCBI chr10:89,290,096...89,369,484
Ensembl chr10:89,290,096...89,369,447
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 susceptibility ISO CTD Direct Evidence: marker/mechanism|therapeutic
associated with tuberculosis ;DNA:SNP,haplotypes:promoter: (rs3814055) (human)
CTD
RGD
PMID:19797606 PMID:28058446 PMID:31490979 RGD:40902984 NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:14742670 PMID:25656644 PMID:28058446 NCBI chr 1:171,041,503...171,046,414
Ensembl chr 1:171,041,539...171,048,270
JBrowse link
G Nr2f2 nuclear receptor subfamily 2, group F, member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 7:70,001,694...70,016,494
Ensembl chr 7:70,001,692...70,016,483
JBrowse link
G Nr5a2 nuclear receptor subfamily 5, group A, member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29515023 NCBI chr 1:136,770,300...136,888,186
Ensembl chr 1:136,770,309...136,888,186
JBrowse link
G Nrep neuronal regeneration related protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr18:33,570,072...33,597,444
Ensembl chr18:33,570,072...33,597,082
JBrowse link
G Nus1 NUS1 dehydrodolichyl diphosphate synthase subunit ISO CTD Direct Evidence: therapeutic CTD PMID:33812996 NCBI chr10:52,293,643...52,316,288
Ensembl chr10:52,293,643...52,316,279
JBrowse link
G Oas1a 2'-5' oligoadenylate synthetase 1A EXP CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr 5:121,034,319...121,045,605
Ensembl chr 5:121,034,319...121,045,584
JBrowse link
G Ociad1 OCIA domain containing 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 5:73,450,093...73,471,420
Ensembl chr 5:73,450,127...73,471,412
JBrowse link
G Ogdh oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:6,241,597...6,309,094
Ensembl chr11:6,241,633...6,306,642
JBrowse link
G Or51e2 olfactory receptor family 51 subfamily E member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 7:102,389,928...102,408,678
Ensembl chr 7:102,387,718...102,408,678
JBrowse link
G P4hb prolyl 4-hydroxylase, beta polypeptide ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:120,451,124...120,464,079
Ensembl chr11:120,451,124...120,464,079
JBrowse link
G Pah phenylalanine hydroxylase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr10:87,357,657...87,419,999
Ensembl chr10:87,357,657...87,419,998
JBrowse link
G Pan2 PAN2 poly(A) specific ribonuclease subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr10:128,135,106...128,157,227
Ensembl chr10:128,139,204...128,157,227
JBrowse link
G Panx1 pannexin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29246445 NCBI chr 9:14,917,081...14,956,774
Ensembl chr 9:14,913,424...14,956,774
JBrowse link
G Park7 Parkinson disease (autosomal recessive, early onset) 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:150,981,590...150,994,378
Ensembl chr 4:150,981,590...150,998,894
JBrowse link
G Pcolce procollagen C-endopeptidase enhancer protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 5:137,603,369...137,609,666
Ensembl chr 5:137,603,365...137,612,046
JBrowse link
G Pcx pyruvate carboxylase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr19:4,560,500...4,671,780
Ensembl chr19:4,560,500...4,671,780
JBrowse link
G Pcyt1a phosphate cytidylyltransferase 1, choline, alpha isoform ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr16:32,249,739...32,293,883
Ensembl chr16:32,249,739...32,293,888
JBrowse link
G Pdk4 pyruvate dehydrogenase kinase, isoenzyme 4 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:21182459 PMID:31809757 NCBI chr 6:5,483,351...5,496,278
Ensembl chr 6:5,483,351...5,496,309
JBrowse link
G Pdlim5 PDZ and LIM domain 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 3:141,945,346...142,101,480
Ensembl chr 3:141,945,351...142,101,457
JBrowse link
G Pex11a peroxisomal biogenesis factor 11 alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 7:79,385,705...79,392,879
Ensembl chr 7:79,385,705...79,392,879
JBrowse link
G Pgm1 phosphoglucomutase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:99,786,648...99,844,491
Ensembl chr 4:99,786,611...99,844,491
JBrowse link
G Plat plasminogen activator, tissue ISO CTD Direct Evidence: marker/mechanism CTD PMID:22507835 NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
JBrowse link
G Plg plasminogen ISO CTD Direct Evidence: marker/mechanism CTD PMID:22507835 NCBI chr17:12,597,496...12,638,271
Ensembl chr17:12,597,495...12,638,272
JBrowse link
G Pls3 plastin 3 (T-isoform) ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr  X:74,829,259...74,918,788
Ensembl chr  X:74,829,260...74,918,788
JBrowse link
G Pnp2 purine-nucleoside phosphorylase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr14:51,193,598...51,202,206
Ensembl chr14:51,193,449...51,202,206
JBrowse link
G Pnrc1 proline-rich nuclear receptor coactivator 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:33,245,423...33,248,787
Ensembl chr 4:33,245,423...33,290,163
JBrowse link
G Polg polymerase (DNA directed), gamma susceptibility
no_association
ISO
IAGP
CTD Direct Evidence: marker/mechanism
DNA:missense mutation:cds:p.W748S, p.E1143G (2243G>C, 3428A>G) (human)
DNA:missense mutations:cds:p.Q1236H, p.E1143G (33708G>T, 3428A>G) (human)
CTD
RGD
PMID:18208989 PMID:20138553 PMID:25065347 PMID:30255931 RGD:15039302, RGD:15039297 NCBI chr 7:79,095,979...79,117,659
Ensembl chr 7:79,095,979...79,116,110
JBrowse link
G Polr2g polymerase (RNA) II (DNA directed) polypeptide G ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr19:8,770,493...8,775,921
Ensembl chr19:8,770,491...8,775,941
JBrowse link
G Pon1 paraoxonase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 6:5,168,090...5,193,987
Ensembl chr 6:5,168,090...5,193,946
JBrowse link
G Ppara peroxisome proliferator activated receptor alpha IDA
ISO
LPS-induced acute liver damage
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:24385052 PMID:21262334 RGD:5509941 NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
JBrowse link
G Pparg peroxisome proliferator activated receptor gamma IEP mRNA, protein:decreased expression:liver RGD PMID:26599535 RGD:11554658 NCBI chr 6:115,337,840...115,467,365
Ensembl chr 6:115,337,912...115,467,360
JBrowse link
G Pptc7 PTC7 protein phosphatase homolog ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 5:122,422,461...122,462,344
Ensembl chr 5:122,422,428...122,462,344
JBrowse link
G Prkaa1 protein kinase, AMP-activated, alpha 1 catalytic subunit treatment IEP RGD PMID:29091898 RGD:15090820 NCBI chr15:5,172,641...5,211,380
Ensembl chr15:5,173,343...5,211,380
JBrowse link
G Prkcd protein kinase C, delta ISO CTD Direct Evidence: therapeutic CTD PMID:30393195 NCBI chr14:30,317,310...30,348,637
Ensembl chr14:30,317,311...30,348,167
JBrowse link
G Prkdc protein kinase, DNA activated, catalytic polypeptide ISO CTD Direct Evidence: marker/mechanism CTD PMID:21224054 NCBI chr16:15,455,698...15,660,103
Ensembl chr16:15,455,730...15,660,099
JBrowse link
G Ptf1a pancreas specific transcription factor, 1a ISO CTD Direct Evidence: therapeutic CTD PMID:21182459 NCBI chr 2:19,450,474...19,452,312
Ensembl chr 2:19,450,474...19,452,312
JBrowse link
G Ptges2 prostaglandin E synthase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31444509 NCBI chr 2:32,285,902...32,292,752
Ensembl chr 2:32,285,908...32,295,784
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 treatment ISO
IEP
CTD Direct Evidence: therapeutic CTD
RGD
PMID:11743745 PMID:29091898 RGD:15090820 NCBI chr 1:149,975,782...149,983,985
Ensembl chr 1:149,975,782...149,983,978
JBrowse link
G Pum1 pumilio RNA-binding family member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:130,390,509...130,508,875
Ensembl chr 4:130,390,632...130,508,875
JBrowse link
G Pygl liver glycogen phosphorylase ISO
IEP
CTD Direct Evidence: marker/mechanism
protein:increased expression:serum (rat)
CTD
RGD
PMID:25231249 PMID:25336395 RGD:21079733 NCBI chr12:70,237,589...70,274,457
Ensembl chr12:70,237,585...70,278,262
JBrowse link
G Rasa1 RAS p21 protein activator 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr13:85,362,818...85,437,605
Ensembl chr13:85,362,899...85,437,249
JBrowse link
G Rbp1 retinol binding protein 1, cellular ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 9:98,305,014...98,328,604
Ensembl chr 9:98,305,014...98,328,628
JBrowse link
G Rdh13 retinol dehydrogenase 13 (all-trans and 9-cis) ISO CTD Direct Evidence: marker/mechanism CTD PMID:27865848 NCBI chr 7:4,428,664...4,474,279
Ensembl chr 7:4,427,769...4,448,648
JBrowse link
G Reep5 receptor accessory protein 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr18:34,477,938...34,508,044
Ensembl chr18:34,477,938...34,507,123
JBrowse link
G Rgn regucalcin ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr  X:20,416,005...20,428,328
Ensembl chr  X:20,416,026...20,428,328
JBrowse link
G Ripk3 receptor-interacting serine-threonine kinase 3 ISO
IEP
CTD Direct Evidence: therapeutic
protein:increased expression:liver (mouse)
CTD
RGD
PMID:26769846 PMID:28205631 RGD:127229945 NCBI chr14:56,022,452...56,026,314
Ensembl chr14:56,022,452...56,026,322
JBrowse link
G S100a11 S100 calcium binding protein A11 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:93,427,803...93,433,595
Ensembl chr 3:93,427,795...93,433,594
JBrowse link
G Selenbp1 selenium binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 3:94,840,394...94,852,069
Ensembl chr 3:94,840,367...94,852,069
JBrowse link
G Sema3a sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A ISO CTD Direct Evidence: therapeutic CTD PMID:33290778 NCBI chr 5:13,174,789...13,653,453
Ensembl chr 5:13,175,381...13,652,533
JBrowse link
G Sema4a sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A ISO CTD Direct Evidence: marker/mechanism CTD PMID:33290778 NCBI chr 3:88,343,266...88,368,500
Ensembl chr 3:88,343,266...88,368,489
JBrowse link
G Senp2 SUMO/sentrin specific peptidase 2 ISO CTD Direct Evidence: therapeutic CTD PMID:29535048 NCBI chr16:21,828,182...21,868,019
Ensembl chr16:21,828,234...21,868,019
JBrowse link
G Serpina6 serine (or cysteine) peptidase inhibitor, clade A, member 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr12:103,612,889...103,623,477
Ensembl chr12:103,612,889...103,623,471
JBrowse link
G Serpine1 serine (or cysteine) peptidase inhibitor, clade E, member 1 treatment ISO associated with precursor lymphoblastic lymphoma/leukemia;DNA:SNPs: :DNA:SNPs: :677C>T, 1298A>C(human) RGD PMID:23183238 RGD:14696750 NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
JBrowse link
G Serping1 serine (or cysteine) peptidase inhibitor, clade G, member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 2:84,595,704...84,605,778
Ensembl chr 2:84,595,731...84,605,788
JBrowse link
G Sesn2 sestrin 2 ISO CTD Direct Evidence: therapeutic CTD PMID:28209544 NCBI chr 4:132,220,115...132,237,767
Ensembl chr 4:132,219,343...132,237,812
JBrowse link
G Sgf29 SAGA complex associated factor 29 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 7:126,247,558...126,271,951
Ensembl chr 7:126,248,481...126,272,097
JBrowse link
G Shc1 src homology 2 domain-containing transforming protein C1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 PMID:32659284 NCBI chr 3:89,325,858...89,337,336
Ensembl chr 3:89,325,750...89,337,334
JBrowse link
G Slc10a1 solute carrier family 10 (sodium/bile acid cotransporter family), member 1 ISO mRNA:decreased expression:liver (rat) RGD PMID:28827769 RGD:15045609 NCBI chr12:80,999,959...81,015,479
Ensembl chr12:80,999,957...81,015,479
JBrowse link
G Slc10a7 solute carrier family 10 (sodium/bile acid cotransporter family), member 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 8:79,235,957...79,460,641
Ensembl chr 8:79,235,975...79,460,632
JBrowse link
G Slc13a4 solute carrier family 13 (sodium/sulfate symporters), member 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 6:35,244,888...35,285,061
Ensembl chr 6:35,244,892...35,285,066
JBrowse link
G Slc22a8 solute carrier family 22 (organic anion transporter), member 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr19:8,568,545...8,589,199
Ensembl chr19:8,568,618...8,589,199
JBrowse link
G Slc25a29 solute carrier family 25 (mitochondrial carrier, palmitoylcarnitine transporter), member 29 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr12:108,791,804...108,801,802
Ensembl chr12:108,791,799...108,801,809
JBrowse link
G Slc7a5 solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 treatment ISO RGD PMID:9200186 RGD:151357001 NCBI chr 8:122,607,885...122,634,425
Ensembl chr 8:122,607,889...122,634,433
JBrowse link
G Slpi secretory leukocyte peptidase inhibitor ISO CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr 2:164,195,990...164,230,861
Ensembl chr 2:164,195,990...164,231,015
JBrowse link
G Snx18 sorting nexin 18 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr13:113,728,715...113,755,100
Ensembl chr13:113,728,715...113,755,100
JBrowse link
G Sod1 superoxide dismutase 1, soluble ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 PMID:27349771 NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
JBrowse link
G Sod2 superoxide dismutase 2, mitochondrial treatment
severity
susceptibility
ISO
IMP
CTD Direct Evidence: marker/mechanism
associated with acute lymphoblastic leukemia;DNA:SNP: :(rs4880)(human)
DNA:SNP:cds:p.Val16Ala(human)
CTD
RGD
PMID:25226513 PMID:27019981 PMID:19647030 PMID:19332662 PMID:20578157 RGD:11060605, RGD:26923961, RGD:26923959, RGD:26923957 NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
JBrowse link
G Sod3 superoxide dismutase 3, extracellular ISO CTD Direct Evidence: therapeutic CTD PMID:11529661 NCBI chr 5:52,521,146...52,527,080
Ensembl chr 5:52,521,133...52,528,760
JBrowse link
G Sord sorbitol dehydrogenase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12763371 NCBI chr 2:122,065,320...122,095,818
Ensembl chr 2:122,065,230...122,095,821
JBrowse link
G Sorl1 sortilin-related receptor, LDLR class A repeats-containing ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 9:41,876,005...42,035,593
Ensembl chr 9:41,876,016...42,035,593
JBrowse link
G Spin2c spindlin family, member 2C ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr  X:152,615,000...152,617,239
Ensembl chr  X:152,615,221...152,617,239
JBrowse link
G Spp1 secreted phosphoprotein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
JBrowse link
G Srp72 signal recognition particle 72 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 5:77,122,548...77,147,782
Ensembl chr 5:77,122,530...77,147,784
JBrowse link
G Stat4 signal transducer and activator of transcription 4 severity IEP protein:increased phosphorylation:liver, inflammatory cell (mouse)
mRNA:increased expression:liver, macrophage (mouse)
RGD PMID:24731448 PMID:23876342 RGD:25671417, RGD:25671422 NCBI chr 1:52,026,265...52,146,348
Ensembl chr 1:52,026,307...52,146,348
JBrowse link
G Sult1c1 sulfotransferase family, cytosolic, 1C, member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr17:54,268,643...54,297,659
Ensembl chr17:54,268,643...54,297,702
JBrowse link
G Sult1e1 sulfotransferase family 1E, member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 5:87,723,827...87,739,470
Ensembl chr 5:87,723,828...87,739,453
JBrowse link
G Sult2b1 sulfotransferase family, cytosolic, 2B, member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27052460 NCBI chr 7:45,379,405...45,409,096
Ensembl chr 7:45,379,407...45,434,093
JBrowse link
G Suox sulfite oxidase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr10:128,505,756...128,509,787
Ensembl chr10:128,505,763...128,509,942
JBrowse link
G Tagln2 transgelin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:172,327,813...172,334,942
Ensembl chr 1:172,327,614...172,334,947
JBrowse link
G Taldo1 transaldolase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19436114 NCBI chr 7:140,972,073...140,982,889
Ensembl chr 7:140,972,112...140,982,881
JBrowse link
G Tbxa2r thromboxane A2 receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:22206755 NCBI chr10:81,164,102...81,171,008
Ensembl chr10:81,164,565...81,171,006
JBrowse link
G Tctn1 tectonic family member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr 5:122,377,558...122,402,557
Ensembl chr 5:122,375,911...122,402,523
JBrowse link
G Tgfb1 transforming growth factor, beta 1 treatment IEP RGD PMID:27516150 RGD:14995464 NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
JBrowse link
G Tgfbr1 transforming growth factor, beta receptor I ISO CTD Direct Evidence: marker/mechanism CTD PMID:28560358 NCBI chr 4:47,353,222...47,414,926
Ensembl chr 4:47,353,222...47,414,931
JBrowse link
G Thpo thrombopoietin ISO CTD Direct Evidence: therapeutic CTD PMID:33122006 NCBI chr16:20,543,204...20,553,261
Ensembl chr16:20,543,204...20,553,261
JBrowse link
G Tlr4 toll-like receptor 4 disease_progression ISO RGD PMID:17504260 RGD:14697733 NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
JBrowse link
G Tlr5 toll-like receptor 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30508503 NCBI chr 1:182,782,317...182,804,010
Ensembl chr 1:182,782,353...182,804,010
JBrowse link
G Tlr9 toll-like receptor 9 severity
treatment
ISO
IMP
protein:increased expression: blood, neutrophil (human) RGD PMID:26457748 PMID:19164858 PMID:23509352 RGD:18337465, RGD:18337476, RGD:18337473 NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
JBrowse link
G Tmed7 transmembrane p24 trafficking protein 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr18:46,718,995...46,730,602
Ensembl chr18:46,693,302...46,730,602
JBrowse link
G Tmem117 transmembrane protein 117 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr15:94,527,066...94,993,978
Ensembl chr15:94,527,113...94,993,979
JBrowse link
G Tmem164 transmembrane protein 164 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr  X:141,463,343...141,626,490
Ensembl chr  X:141,464,402...141,626,490
JBrowse link
G Tmem38b transmembrane protein 38B ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 4:53,825,988...53,862,019
Ensembl chr 4:53,826,045...53,862,019
JBrowse link
G Tnf tumor necrosis factor treatment
severity
ISO
IEP
IMP
protein:increased expression:serum (rat)
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
RGD
PMID:7532385 PMID:9696492 PMID:17709330 PMID:19638433 PMID:20623750 More... RGD:10450531, RGD:15090820, RGD:15036799, RGD:14995485, RGD:14995437, RGD:14995435, RGD:14995430, RGD:14995429, RGD:14975281, RGD:14696804 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Trf transferrin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 9:103,086,075...103,107,485
Ensembl chr 9:103,081,200...103,107,643
JBrowse link
G Trpm2 transient receptor potential cation channel, subfamily M, member 2 IMP RGD PMID:24569808 RGD:9999438 NCBI chr10:77,743,556...77,805,746
Ensembl chr10:77,743,556...77,806,397
JBrowse link
G Ttr transthyretin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr18:20,797,266...20,807,383
Ensembl chr18:20,798,337...20,807,378
JBrowse link
G Tuba1a tubulin, alpha 1A ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr15:98,847,728...98,851,382
Ensembl chr15:98,847,718...98,851,584
JBrowse link
G Tubb4b tubulin, beta 4B class IVB ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 2:25,112,170...25,114,714
Ensembl chr 2:25,112,172...25,114,714
JBrowse link
G Uba5 ubiquitin-like modifier activating enzyme 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 9:103,923,786...103,940,767
Ensembl chr 9:103,923,798...103,940,333
JBrowse link
G Ugt1a1 UDP glucuronosyltransferase 1 family, polypeptide A1 susceptibility ISO DNA:SNP:exon (rs4148323)(human) RGD PMID:28900877 RGD:14694824 NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
JBrowse link
G Ugt1a9 UDP glucuronosyltransferase 1 family, polypeptide A9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 1:87,998,501...88,147,724
Ensembl chr 1:87,998,522...88,146,719
JBrowse link
G Unc93b1 unc-93 homolog B1, TLR signaling regulator ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr19:3,985,171...3,999,340
Ensembl chr19:3,985,186...3,999,340
JBrowse link
G Usp5 ubiquitin specific peptidase 5 (isopeptidase T) ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:124,791,982...124,806,447
Ensembl chr 6:124,791,982...124,806,447
JBrowse link
G Vegfa vascular endothelial growth factor A treatment ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:25231249 PMID:17784864 RGD:15003197 NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
JBrowse link
G Vim vimentin ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637
JBrowse link
G Vwf Von Willebrand factor ISO protein:increased expression:liver:
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:28527913 PMID:7531171 RGD:11079232 NCBI chr 6:125,529,911...125,663,642
Ensembl chr 6:125,523,737...125,663,642
JBrowse link
G Wasl WASP like actin nucleation promoting factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 6:24,613,809...24,665,185
Ensembl chr 6:24,613,804...24,665,008
JBrowse link
G Xrcc1 X-ray repair complementing defective repair in Chinese hamster cells 1 susceptibility IMP DNA:haploinsufficiency: : (mouse) RGD PMID:21737425 RGD:15036796 NCBI chr 7:24,246,124...24,272,863
Ensembl chr 7:24,245,714...24,272,865
JBrowse link
G Xylb xylulokinase homolog (H. influenzae) ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 9:119,186,447...119,222,863
Ensembl chr 9:119,186,447...119,222,863
JBrowse link
G Zdhhc23 zinc finger, DHHC domain containing 23 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr16:43,785,396...43,800,295
Ensembl chr16:43,785,396...43,800,154
JBrowse link
Chloramphenicol Toxicity term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G mt-Rnr2 16S rRNA, mitochondrial ISO ClinVar Annotator: match by term: Chloramphenicol resistance ClinVar PMID:6273808 PMID:7219548 NCBI chr MT:1,094...2,675
Ensembl chr MT:1,094...2,675
JBrowse link
drug allergy term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcc2 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20216337 NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
JBrowse link
G Ace angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18727619 NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
JBrowse link
G Adora1 adenosine A1 receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:19019667 NCBI chr 1:134,126,953...134,163,195
Ensembl chr 1:134,126,961...134,163,169
JBrowse link
G Adora2a adenosine A2a receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:19019667 NCBI chr10:75,152,711...75,170,626
Ensembl chr10:75,152,711...75,170,618
JBrowse link
G Ccl11 chemokine (C-C motif) ligand 11 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14616128 NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781
JBrowse link
G Ccl24 chemokine (C-C motif) ligand 24 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14616128 NCBI chr 5:135,598,789...135,601,977
Ensembl chr 5:135,598,791...135,601,903
JBrowse link
G Cyp2c65 cytochrome P450, family 2, subfamily c, polypeptide 65 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
JBrowse link
G Cyp2c66 cytochrome P450, family 2, subfamily c, polypeptide 66 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr19:39,102,342...39,175,200
Ensembl chr19:39,102,342...39,175,516
JBrowse link
G Cysltr1 cysteinyl leukotriene receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16630147 NCBI chr  X:105,617,952...105,647,329
Ensembl chr  X:105,617,952...105,647,285
JBrowse link
G Cysltr2 cysteinyl leukotriene receptor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15970796 NCBI chr14:73,263,515...73,286,554
Ensembl chr14:73,263,043...73,286,554
JBrowse link
G Fasl Fas ligand (TNF superfamily, member 6) ISO CTD Direct Evidence: marker/mechanism CTD PMID:19706026 NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
JBrowse link
G Fcer1a Fc receptor, IgE, high affinity I, alpha polypeptide ISO CTD Direct Evidence: marker/mechanism CTD PMID:17125826 PMID:20485159 NCBI chr 1:173,048,836...173,054,799
Ensembl chr 1:173,048,851...173,054,781
JBrowse link
G Fcer1g Fc receptor, IgE, high affinity I, gamma polypeptide ISO CTD Direct Evidence: marker/mechanism CTD PMID:18534082 PMID:18595682 NCBI chr 1:171,057,141...171,061,918
Ensembl chr 1:171,057,141...171,061,934
JBrowse link
G Gstm1 glutathione S-transferase, mu 1 susceptibility ISO DNA:deletion: :
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:20485159 PMID:11007341 RGD:5491000 NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
JBrowse link
G Gstp1 glutathione S-transferase, pi 1 susceptibility ISO associated with Acquired Immunodeficiency Syndrome;DNA:polymorphism:exon:A>G313 (rs1695) (human)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:20485159 PMID:16297214 RGD:5490995 NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
JBrowse link
G Gstt1 glutathione S-transferase, theta 1 susceptibility ISO DNA:deletion: : RGD PMID:11007341 RGD:5491000 NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
JBrowse link
G Gzmb granzyme B ISO CTD Direct Evidence: marker/mechanism CTD PMID:19706026 NCBI chr14:56,496,293...56,499,791
Ensembl chr14:56,496,295...56,499,717
JBrowse link
G H2-Eb1 histocompatibility 2, class II antigen E beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648
JBrowse link
G H2-M2 histocompatibility 2, M region locus 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11943262 PMID:15024131 PMID:17392574 PMID:18007983 NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443
JBrowse link
G Hnmt histamine N-methyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr 2:23,892,923...23,939,756
Ensembl chr 2:23,892,922...23,939,406
JBrowse link
G Hspa1a heat shock protein 1A ISO CTD Direct Evidence: marker/mechanism CTD PMID:16538175 NCBI chr17:35,188,335...35,191,132
Ensembl chr17:35,188,166...35,191,132
JBrowse link
G Hspa1l heat shock protein 1-like ISO CTD Direct Evidence: marker/mechanism CTD PMID:16538175 NCBI chr17:35,191,679...35,198,204
Ensembl chr17:35,191,679...35,198,261
JBrowse link
G Il10 interleukin 10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19222424 PMID:20485159 NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
JBrowse link
G Il13 interleukin 13 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
JBrowse link
G Il2 interleukin 2 ISO RGD PMID:1549655 RGD:8662975 NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
JBrowse link
G Il4 interleukin 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15867870 PMID:20485159 NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
JBrowse link
G Il4ra interleukin 4 receptor, alpha EXP CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr 7:125,151,443...125,178,646
Ensembl chr 7:125,151,292...125,178,646
JBrowse link
G Ltc4s leukotriene C4 synthase ISO CTD Direct Evidence: marker/mechanism CTD PMID:16433794 NCBI chr11:50,127,288...50,129,378
Ensembl chr11:50,127,288...50,129,443
JBrowse link
G Ms4a2 membrane-spanning 4-domains, subfamily A, member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16839402 PMID:18534082 PMID:20485159 NCBI chr19:11,592,881...11,601,154
Ensembl chr19:11,592,887...11,601,083
JBrowse link
G Nat2 N-acetyltransferase 2 (arylamine N-acetyltransferase) ISO CTD Direct Evidence: marker/mechanism CTD PMID:20485159 PMID:20602614 PMID:21572414 NCBI chr 8:67,947,527...67,955,296
Ensembl chr 8:67,947,510...67,955,236
JBrowse link
G Nlrp3 NLR family, pyrin domain containing 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19767079 NCBI chr11:59,432,395...59,457,781
Ensembl chr11:59,432,394...59,457,782
JBrowse link
G Postn periostin, osteoblast specific factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:18391768 NCBI chr 3:54,266,688...54,298,462
Ensembl chr 3:54,268,530...54,298,458
JBrowse link
G Ptger3 prostaglandin E receptor 3 (subtype EP3) ISO CTD Direct Evidence: marker/mechanism CTD PMID:20587336 NCBI chr 3:157,272,459...157,350,392
Ensembl chr 3:157,272,529...157,351,525
JBrowse link
G Ptgs1 prostaglandin-endoperoxide synthase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17508966 NCBI chr 2:36,106,758...36,142,287
Ensembl chr 2:36,120,438...36,142,284
JBrowse link
G Tac1 tachykinin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21233199 NCBI chr 6:7,555,061...7,562,978
Ensembl chr 6:7,554,879...7,565,834
JBrowse link
G Tbxas1 thromboxane A synthase 1, platelet ISO CTD Direct Evidence: marker/mechanism CTD PMID:21449675 NCBI chr 6:38,817,897...39,061,524
Ensembl chr 6:38,852,338...39,061,519
JBrowse link
G Tnf tumor necrosis factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:11294926 PMID:20485159 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Tnfrsf10b tumor necrosis factor receptor superfamily, member 10b ISO CTD Direct Evidence: marker/mechanism CTD PMID:19652058 NCBI chr14:70,004,921...70,021,860
Ensembl chr14:70,004,921...70,021,860
JBrowse link
Drug Eruptions term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Alox5 arachidonate 5-lipoxygenase ISO CTD Direct Evidence: marker/mechanism CTD PMID:16502481 NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
JBrowse link
G Apoa1 apolipoprotein A-I ISO CTD Direct Evidence: marker/mechanism CTD PMID:21055120 NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
JBrowse link
G Apoc2 apolipoprotein C2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21055120 NCBI chr 7:19,405,504...19,411,866
Ensembl chr 7:19,405,504...19,411,866
JBrowse link
G Apoc3 apolipoprotein C-III ISO CTD Direct Evidence: marker/mechanism CTD PMID:21055120 NCBI chr 9:46,144,348...46,146,934
Ensembl chr 9:46,144,231...46,146,934
JBrowse link
G Bdnf brain derived neurotrophic factor IEP mRNA:increased expression:lymph node, ear: RGD PMID:19904815 RGD:8657071 NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
JBrowse link
G C4b complement component 4B (Chido blood group) ISO CTD Direct Evidence: marker/mechanism CTD PMID:21055120 NCBI chr17:34,947,249...34,962,876
Ensembl chr17:34,947,354...34,962,856
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19351467 NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
JBrowse link
G Cyp2c38 cytochrome P450, family 2, subfamily c, polypeptide 38 susceptibility
treatment
ISO DNA:SNP: :Rs4244285(human)
associated with tuberculosis; DNA.polymorphism, haplotype:cds:p.W212X (human)
RGD PMID:23551241 PMID:20941486 RGD:11352742, RGD:124713543 NCBI chr19:39,378,000...39,451,547
Ensembl chr19:39,378,000...39,451,519
JBrowse link
G Cyp2c66 cytochrome P450, family 2, subfamily c, polypeptide 66 susceptibility ISO DNA:SNP: :Rs4244285(human) RGD PMID:23551241 RGD:11352742 NCBI chr19:39,102,342...39,175,200
Ensembl chr19:39,102,342...39,175,516
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19351467 NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
JBrowse link
G Fcer1a Fc receptor, IgE, high affinity I, alpha polypeptide ISO CTD Direct Evidence: marker/mechanism CTD PMID:16502481 NCBI chr 1:173,048,836...173,054,799
Ensembl chr 1:173,048,851...173,054,781
JBrowse link
G H2-Aa histocompatibility 2, class II antigen A, alpha susceptibility ISO DNA:polymorphisms:exon: RGD PMID:16836882 RGD:8547665 NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797
JBrowse link
G H2-Ab1 histocompatibility 2, class II antigen A, beta 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16502481 NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
JBrowse link
G H2-M2 histocompatibility 2, M region locus 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19712599 PMID:29370880 NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443
JBrowse link
G Ifng interferon gamma ISO CTD Direct Evidence: marker/mechanism CTD PMID:31150805 NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
JBrowse link
G Il17a interleukin 17A ISO CTD Direct Evidence: marker/mechanism CTD PMID:31150805 NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
JBrowse link
G Il18 interleukin 18 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18204966 NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
JBrowse link
G Il2 interleukin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31150805 NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
JBrowse link
G Il4 interleukin 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19351467 NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
JBrowse link
G Kng2 kininogen 2 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:1371395 PMID:3034372 NCBI chr16:22,804,602...22,847,851
Ensembl chr16:22,804,604...22,848,232
JBrowse link
G Mpo myeloperoxidase ISO CTD Direct Evidence: marker/mechanism CTD PMID:18204966 NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
JBrowse link
G Mthfr methylenetetrahydrofolate reductase ISO CTD Direct Evidence: marker/mechanism CTD PMID:14723717 NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
JBrowse link
G Rela v-rel reticuloendotheliosis viral oncogene homolog A (avian) ISO CTD Direct Evidence: marker/mechanism CTD PMID:31150805 NCBI chr19:5,687,569...5,698,162
Ensembl chr19:5,687,511...5,698,158
JBrowse link
G Tac1 tachykinin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:1371395 NCBI chr 6:7,555,061...7,562,978
Ensembl chr 6:7,554,879...7,565,834
JBrowse link
G Tnf tumor necrosis factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:31150805 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Ttr transthyretin ISO CTD Direct Evidence: marker/mechanism CTD PMID:21055120 NCBI chr18:20,797,266...20,807,383
Ensembl chr18:20,798,337...20,807,378
JBrowse link
Drug Hypersensitivity Syndrome term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G C1qa complement component 1, q subcomponent, alpha polypeptide ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr 4:136,623,227...136,626,155
Ensembl chr 4:136,623,228...136,626,114
JBrowse link
G C1qb complement component 1, q subcomponent, beta polypeptide ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr 4:136,607,437...136,613,511
Ensembl chr 4:136,607,440...136,613,498
JBrowse link
G C1qc complement component 1, q subcomponent, C chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr 4:136,617,112...136,620,242
Ensembl chr 4:136,617,115...136,620,376
JBrowse link
G Cfhr1 complement factor H-related 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr 1:139,474,802...139,487,960
Ensembl chr 1:139,474,791...139,488,010
JBrowse link
G Crp C-reactive protein, pentraxin-related ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
JBrowse link
G Hspa1l heat shock protein 1-like ISO DNA:polymorphism, haplotype: :p.M493T (human) RGD PMID:15024131 RGD:8662461 NCBI chr17:35,191,679...35,198,204
Ensembl chr17:35,191,679...35,198,261
JBrowse link
G Il1b interleukin 1 beta ISO DNA:SNP:promoter:-511C>T (rs 16944) (human) RGD PMID:23461376 RGD:11051970 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
JBrowse link
G Il1rn interleukin 1 receptor antagonist ISO DNA:SNP:intron:rs2234663 (human) RGD PMID:23461376 RGD:11051970 NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
JBrowse link
G Lbp lipopolysaccharide binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr 2:158,148,413...158,174,772
Ensembl chr 2:158,148,413...158,174,772
JBrowse link
G Lrg1 leucine-rich alpha-2-glycoprotein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr17:56,426,678...56,428,946
Ensembl chr17:56,426,678...56,429,001
JBrowse link
G Orm1 orosomucoid 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr 4:63,262,793...63,266,400
Ensembl chr 4:63,262,797...63,266,400
JBrowse link
G Orm2 orosomucoid 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr 4:63,280,543...63,284,114
Ensembl chr 4:63,280,686...63,284,115
JBrowse link
G Vwf Von Willebrand factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr 6:125,529,911...125,663,642
Ensembl chr 6:125,523,737...125,663,642
JBrowse link
Drug-Induced Dyskinesia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abat 4-aminobutyrate aminotransferase ISO RGD PMID:7740056 PMID:6445277 RGD:1598524, RGD:10047091 NCBI chr16:8,331,293...8,439,432
Ensembl chr16:8,331,293...8,439,432
JBrowse link
G Cacna1d calcium channel, voltage-dependent, L type, alpha 1D subunit ISO RGD PMID:18947822 RGD:6906919 NCBI chr14:29,761,898...30,213,113
Ensembl chr14:29,761,896...30,213,412
JBrowse link
G Cat catalase ISO CTD Direct Evidence: marker/mechanism CTD PMID:19109989 NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
JBrowse link
G Cck cholecystokinin ISO CTD Direct Evidence: therapeutic CTD PMID:2320253 NCBI chr 9:121,318,890...121,324,760
Ensembl chr 9:121,318,890...121,324,760
JBrowse link
G Comt catechol-O-methyltransferase ISO RGD PMID:16437585 RGD:2289781 NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602
JBrowse link
G Cyp2d22 cytochrome P450, family 2, subfamily d, polypeptide 22 ISO RGD PMID:12629505 RGD:1358549 NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
JBrowse link
G Dbn1 drebrin 1 ISO levodopainduced; protein:increased expression:striatum: RGD PMID:23241013 RGD:10398811 NCBI chr13:55,621,241...55,635,959
Ensembl chr13:55,621,242...55,635,924
JBrowse link
G Ddc dopa decarboxylase ISO associated with Parkinson Disease; protein:decreased expression:striatum (rat) RGD PMID:20232137 RGD:5128860 NCBI chr11:11,764,101...11,848,144
Ensembl chr11:11,764,101...11,848,144
JBrowse link
G Drd1 dopamine receptor D1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:7845605 PMID:10858612 PMID:16982285 PMID:19520364 NCBI chr13:54,205,202...54,209,677
Ensembl chr13:54,205,202...54,209,724
JBrowse link
G Drd2 dopamine receptor D2 ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:7845605 PMID:10534246 PMID:14629710 PMID:18707801 RGD:2311579 NCBI chr 9:49,251,633...49,319,477
Ensembl chr 9:49,251,927...49,319,477
JBrowse link
G Drd3 dopamine receptor D3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20945430 NCBI chr16:43,574,285...43,646,353
Ensembl chr16:43,574,389...43,643,295
JBrowse link
G